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 BARTONELLA CLARRIDGEIAE:  INVASION OF HUMAN MICROVASCULAR 
ENDOTHELIAL CELLS AND ROLE OF FLAGELLA IN VIRULENCE 
 
by 
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Under the Direction of Barbara R. Baumstark, Ph.D. 
 
ABSTRACT 
 
B. henselae, B. bacilliformis and B. quintana are capable of causing vasoproliferative 
diseases in humans by modulating apoptosis and proliferation of endothelial cells.  Bartonella 
clarridgeiae, a close relative of the pathogenic Bartonellae, has been implicated in human disease 
but has not yet been isolated from a human patient.  Both B. bacilliformis and B. clarridgeiae have 
flagella and a flagellar type 3 secretion system, while B. henselae and B. quintana do not.  We 
created 2 non-motile mutants of B. clarridgeiae by interrupting the flagellin gene, flaA, or the 
flagellar motor genes, motBC.  We investigated whether B. clarridgeiae could invade human 
endothelial cells (HMECs) and if functional flagella were important for invasion.  The non-motile 
mutants and the wild-type strain were capable of entering HMECs in vitro.  The flaA mutant was 
deficient in attachment, but the HMECs in culture with the flaA mutant demonstrated increased 
proliferation.  The motBC mutant showed enhanced invasion.  Differential secretion of proteins was 
  
revealed by 2-D electrophoresis and MALDI-TOF analysis of secretomes from the co-cultures 
compared to uninfected HMECs.  HMECS infected with wild-type B. clarridgeiae secreted proteins 
indicative of proliferation.  The flaA mutant induced the secretion of proteins involved in 
cytoskeletal rearrangement, cell migration, and proliferation.  The motBC-infected HMECs showed 
signs of hypoxia.  The co-chaperonin GroES was found in higher concentration in the supernatant 
of the hyper-invasive motBC strain/HMEC co-culture than the wild-type co-culture and was found 
at a very low concentration in the flaA culture supernatant.  Cross-talk between secretion systems is 
suggested. 
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INTRODUCTION 
 
The Genus Bartonella 
Bartonella clarridgeiae is one of more than 19 bacterial species belonging to the genus 
Bartonella.  From 1909 until 1993, this genus contained only one species, B. bacilliformis.  
Brenner et al. determined from the results of 16S rRNA sequence analysis, DNA-DNA 
hybridization, guanosine plus cytosine content and phenotypic characteristics that several species 
in the genus Rochalimaea were very closely related to B. bacilliformis (Brenner et al.,1993).  In 
1993 the two genera were combined, and B. quintana, B. vinsonii, B. henselae and B. elizabethae 
were included with B. bacilliformis in the genus.  A similar event took place in 1995 when the 
genus Grahamella was combined with Bartonella, and B. talpae, B. peromysci, B. grahamii, B. 
taylorii and B. doshiae joined the genus.  This brought the number of Bartonella species to 10,  
although the original strains of B. talpae and B. peromysci were found to be no longer viable 
(Birtles et al.,1995).  Further studies culturing blood from wild and domestic animals brought 
about the discoveries of B. schoenbuchensis and B. capreoli from deer, B. alsatica from wild 
rabbits, B. tribocorum from wild rats, B. vinsonii subspecies berkhoffii from domestic dogs, B. 
koehlerae from cats, B. chomelii and B. bovis Bermond et al from cattle, B. birtlesii and B. 
vinsonii subspecies arupensis from mice.  B. weissi and B. washoensis are unofficial names of 
two additional species.  B. weissi was recovered from cats and later was found to be identical by 
16S rRNA gene sequence to B. bovis Bermond et al (Bermond et al.,2002), and B. washoensis 
was reported in ground squirrels and a dog (Chomel et al.,2003; Kosoy et al.,2003).  Other 
species with no official taxonomic acceptance are B. australis, B. phoceenis, B. rattimassiliensis, 
and B. tamiae.  The Family Bartonellaceae is one of 10 Families in the Order Rhizobiales.  Other 
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Families include Brucellaceae and Rhizobiaceae (Figure 1). The genus Bartonella is 
characterized as Gram negative, rod-shaped bacteria that grow best in aerobic conditions on 
media that contains 5% sheep, horse or rabbit blood (Birtles et al.,1995).  B. bacilliformis grows 
best at 25  while many other species grow at 37  (Birtles et al.,1995).   The G+C content of the 
genomic DNA is 38.5 to 41 mol% (Birtles et al.,1995).  The type strain of the genus is B. 
bacilliformis. 
Figure 1.  Neighbor-joining phylogenetic tree of some members of the Order Rhizobiales.  
Phylogeny based on 16S rRNA gene sequence alignment of Bradyrhizobium japonicum, 
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Brucella (Br.) species, Ochrobactrum anthropi, Mesorhizobium loti, Sinorhizobium meliloti, 
Agrobacterium tumefaciens, and 16 Bartonella species. 
Several Bartonella species have been implicated in human disease, and the spectrum of 
disease that they cause is vast.  B. bacilliformis is the causative agent of bartonellosis, also 
known as Carrion‟s disease, and was first identified in 1905 by Peruvian microbiologist Alberto 
Barton.  B. bacilliformis is transmitted by the bite of an infected sand fly, Lutzomyia spp., that 
live at an altitude between 2000 and 9000 feet in the Andes Mountains of Peru, Columbia and 
Ecuador (Garcia-Caceres and Garcia,1991; Maurin et al.,1997).  In the initial acute hematic 
phase of bartonellosis known as Oroya fever, B. bacilliformis invades and lyses red blood cells 
causing severe haemolytic anemia and a high fever (Chamberlin et al.,2002).  In many cases of 
untreated bartonellosis, more than 50% of the erythrocytes are lysed, and the fatality rate can be 
as high as 90% (Garcia-Caceres and Garcia,1991; Maguina et al.,2001).  In the study of Maguina 
et al, 65% of the patients in the acute phase of bartonellosis presented with a hematocrit <19%  
(normal values are 38-46%) (Maguina et al.,2001).  Patients who survive the first phase often 
experience verruga peruana, the chronic eruptive phase of the disease, that begins 2 to 8 weeks 
after the acute phase and is characterized by nodular skin lesions (Maguina et al.,2001).   The 
papules often resemble hemangiomas, a benign tumor caused by rapid proliferation of vascular 
endothelial cells.  However, some verruga peruana lesions resemble malignant tumors 
histologically, and only the detection of B. bacilliformis can support a definitive diagnosis of 
Bartonellosis (Arias-Stella et al.,1986; Arias-Stella et al.,1987; Bhutto et al.,1994). 
The species B. quintana historically has been associated with trench fever during the two 
World Wars and more recently has been isolated from homeless individuals (Drancourt et 
al.,1995; Brouqui et al.,1996; Jackson and Spach,1996; Anderson and Neuman,1997; Maurin et 
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al.,1997; Brouqui et al.,1999; Rydkina et al.,1999; Guibal et al.,2001; Foucault et al.,2002; 
Sasaki et al.,2002; Capo et al.,2003; Levy et al.,2003; Rolain et al.,2003).  The vector for B. 
quintana is the human body louse.  Symptoms of B. quintana infection can include leg pain, 
fever that usually lasts approximately 5 days (quintane fever) and headache (Maurin and 
Raoult,1996; Maurin et al.,1997) but symptoms vary by individual.  In a study of 42 homeless 
individuals in Marseille, France, who had B. quintana bacteremia as evidenced by positive blood 
culture, there was no universal symptom although 12 had leg pain, 10 had fever, 8 had headache,  
and18 had lice and skin lesions that itched (Foucault et al.,2002).  B. quintana has been 
confirmed to be a major cause of endocarditis (Spach et al.,1995; Spach et al.,1995; Mainardi et 
al.,1996; Raoult et al.,1996; Jourdain et al.,1998; Guyot et al.,1999; Simon-Vermont et al.,1999; 
Lepidi et al.,2000; Posfay Barbe et al.,2000; Klein et al.,2002; Thiam et al.,2002).  In a study 
published in 2005, 75% of cases of endocarditis without positive blood cultures were attributed 
to B. quintana by serology and PCR (Houpikian and Raoult,2005).   B. quintana has also been 
associated with bacillary angiomatosis (BA), a condition characterized by subcutaneous and 
cutaneous nodules and papules usually affecting immunocompromised patients such as those 
with HIV/AIDS. (Cockerell et al.,1987; Koehler et al.,1992; Santos et al.,2000).   
In addition to B. quintana, B. elizabethae has been implicated in one case of endocarditis 
in a human.  B. vinsonii subspecies berkhoffii has been isolated from dogs with heart disease and 
has recently been isolated from an afebrile human patient with endocarditis (Anderson and 
Neuman,1997; Maurin et al.,1997; Roux et al.,2000). B. washoensis was originally isolated from 
a human patient with cardiac disease (Kosoy et al.,2003). 
B. henselae has been detected in patients with endocarditis, but it is most well-known as 
the major cause of cat scratch disease (CSD) in humans.  In immunocompetent individuals, the 
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most common symptoms of CSD are regional lymphadenopathy near the bite or scratch from a 
cat, low-grade fever, and malaise (Jones,1993; Chen and Gilbert,1994; Hughes and 
Faragher,1994; Flexman et al.,1995).  B. henselae also has been reported to cause a variety of 
systemic infections in both immunocompetent and immunocompromised individuals including 
eye infections such as neuroretinitis, Parinaud‟s syndrome and karatitis, encephalopathy, 
osteomyelitis,  BA, and peliosis hepatitis in adults as well as hepatosplenic lesions and/or 
prolonged fever in children (Holmes et al.,1995; Marra,1995; Wong et al.,1995; Hayem et 
al.,1996; Lamps et al.,1996; Liston and Koehler,1996; Raoult et al.,1996; Schwartzman,1996; 
Yamashita et al.,1996; Breathnach et al.,1997; Cunningham et al.,1997; Jones and 
Cunningham,1997; Sander and Frank,1997; Ahsan et al.,1998; Baorto et al.,1998; Berdague et 
al.,1998; Jacobs and Schutze,1998; Reed et al.,1998; Maggiore et al.,1999; Wade et al.,1999; 
Lohmann et al.,2000; Massei et al.,2000; Dai et al.,2001; De La Rosa et al.,2001; Fournier et 
al.,2001; Meininger et al.,2001; Messina et al.,2001; Numazaki et al.,2001; van Tooren et 
al.,2001; Al-Matar et al.,2002; Besada et al.,2002; Verdon et al.,2002; Komitova et al.,2003; 
Oman et al.,2003; Woestyn et al.,2003; Bookman et al.,2004; Ledina et al.,2004; Rodrick et 
al.,2004). B. shoenbuchensis, B. chomelii and B. capreoli have not been implicated in human 
disease but their presence in cattle and deer pose a potential means of transmission to humans 
(Maillard et al.,2004). 
B. clarridgeaie was first described in 1995 when the organism was isolated from a kitten 
belonging to a B. henselae-positive patient (Clarridge et al.,1995; Collins,1996).  Several studies 
in all four quarters of the world have demonstrated that cats serve as a reservoir for B. 
clarridgeiae and B. henselae and are even coinfected with both species in a small percentage of 
cases (Gurfield et al.,1997; Marston et al.,1999).  Therefore, infection by one species does not 
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confer protection against the other.  B. clarridgeiae has been isolated from dogs with infective 
vegetative valvular endocarditis and in liver specimens from dogs with hepatic disease (Chomel 
et al.,2001; Gillespie et al.,2003).  The number of human infections by B. clarridgeiae is 
unknown.  It has been estimated that there are 24,000 cases of CSD yearly in the US (Jackson et 
al.,1996) and that up to 60% of CSD cases are negative for B. henselae by serology (Yoshida et 
al.,1996).  Because serologic tests for B. clarridgeiae are not usually performed, and because 
Bartonella are difficult to culture, the percentage of CSD cases caused by B. clarridgeiae has not 
been determined. B. clarridgeiae was associated with CSD in a veterinarian bitten by a kitten 
(Kordick et al.,1997) and a CSD case in which a patient developed a “massive chest-wall 
abscess” (Margileth and Baehren,1998).  However, much like the difficulty in the late 1980‟s in 
obtaining data to support B. henselae‟s role in CSD, Koch‟s postulates for B. clarridgeiae as the 
etiologic agent of CSD have not been met.  Kordick et al. reported that no bacteria grew in 
culture from the veterinarian‟s blood, but B. clarridgeiae grew from the blood of the cat that bit 
the man (Kordick et al.,1997).  The veterinarian‟s blood was reactive with the organism cultured 
from the cat in an immunofluorescence assay, and the cat‟s blood gave significant reaction with 
this organism (1:2048), with B. henselae (1:1024) and with B. quintana (1:1280) (Kordick et 
al.,1997).  However, the organism was not isolated from the human, and B. clarridgeiae-specific 
PCR was not attempted from any clinical samples.  Likewise, in the CSD case described by 
Margileth and Baehren, immunofluorescent assay tests using the patient‟s convalescent serum 
were positive for B. clarridgeiae, but no organism was cultured (Margileth and Baehren,1998).   
Cockerell et al.described an HIV-positive patient in 1991 who had reddish or purple 
papules and nodules on the skin of his face, arms, legs and trunk as well as some subcutaneous 
nodules (Cockerell et al.,1991).  A second patient was HIV-negative and had papules on his right 
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forearm.  Neither patient had had exposure to cats, but the second patient had a pet parakeet that 
he let perch on his arm.  Histologic examination of biopsied papules from both patients revealed 
proliferations of capillaries that were lined with cuboidal endothelial cells.  Inflammatory cell 
types were seen (neutrophils, lymphocytes and histiocytes), and Warthin-Starry staining showed 
bacterial aggregates between blood vessels.  Bacteria grew after 10 days in Trypticase Soy Broth 
supplemented with 5% horse serum and 5% Fildes reagent.  The bacteria stained faintly Gram-
negative.  Some of the bacteria had a single polar flagellum while others had multiple unipolar 
flagella when viewed by electron microscopy.  The authors concluded from histologic, 
microscopic and fatty-acid analysis that the organism was closely related to B. bacilliformis.  
While the fatty acid results are characteristic of B. clarridgeiae or B. henselae, B. henselae does 
not have flagella (Boone et al.,2001).  At that time, B. clarridgeiae had not been described.   
There is a possibility, therefore, that these 2 cases represent bacillary angiomatosis caused by B. 
clarridgeiae. 
 
Vector-Borne Transmission 
All Bartonella species are presumed to be transmitted to their primary reservoirs by 
arthropod vectors including fleas, sandflies and lice, as identical organisms have been found in 
the insects and the mammals they use as a blood source (Parola et al.,2002; Parola et al.,2003; 
Rolain et al.,2003; Sanogo et al.,2003; Stevenson et al.,2003; Bown et al.,2004; Kelly et 
al.,2005; Reeves et al.,2005; Sreter-Lancz et al.,2006; Li et al.,2007; Podsiadly et al.,2007; 
Vorou et al.,2007; Tabar et al.,2008).  In a study conducted in France, B. quintana (17%), B. 
koehlerae (4%), B. henselae (11%) and B. clarridgeiae (68%) were detected by PCR in 89 of 
309 cat fleas collected in different regions of the country (Rolain et al.,2003).  Rickettsia felis, B. 
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henselae or B. clarridgeiae were detected by PCR in all 114 cat fleas (Ctenocephalides felis) 
sampled from 3 veterinary clinics in New Zealand, and some fleas had 2 or all 3 of the bacterial 
species present (Kelly et al.,2005).  However, Billeter et al. emphasized that detection of 
Bartonella in a vector does not definitively prove that the arthropod is the mode of transmission; 
replication of the bacteria in the vector and experimental proof of transmission to a host by an 
infected vector is required (Billeter et al.,2008).   The confirmed vectors for Bartonella 
transmission are the sandfly for B. bacilliformis, the human body lousefor B. quintana, the cat 
flea for B. henselae, and  the rodent flea Ctenophthalmus nobilis nobilis for B. grahamii and B. 
taylorii (Billeter et al.,2008).  
 
Pathogenesis 
A common trait of Bartonella species is their affinity for blood (Dehio,2001).  Once 
Bartonella are transmitted to their specific reservoir host(s), the haemotropism results in 
intraerythrocytic bacteremia.  However,  while Bartonellae may persist intraerythrocytically for 
months or years, they usually cause no or only transient symptoms in the animals they infect 
other than humans (Kordick and Breitschwerdt,1995).  The survival of Bartonellae within red 
blood cells may be an adaptation necessary for successful transmission from host to host by the 
arthropod vector (Schulein et al.,2001).  In the human reservoir host, the most extreme result of 
erythrocyte invasion is the severe and often fatal hemolytic anemia caused by B. bacilliformis.  
Other Bartonella spp. do not cause lysis of red blood cells to any significant degree and may use 
the cells as a means of transportation to a primary but still unknown niche.  This niche may be 
the vascular endothelium or perhaps also the reticuloendothelial system including lymph nodes 
and the spleen (Ventura et al.,1999; Durupt et al.,2004; Henriquez et al.,2004; Sykes et al.,2007; 
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Breitschwerdt,2008; Lydy et al.,2008; Scolfaro et al.,2008; van der Veer-Meerkerk and van 
Zaanen,2008).  B. quintana is known to enter human erythrocytes but anemia is not a symptom 
of Trench Fever (Rolain et al.,2002).  Trench fever is also known as fievre quintane due to the 5-
day long fever that may recur multiple times during the illness and for which the causative 
organism is named (Bass et al.,1997).  The recurrence may be the periodicity between the 
invasion of red blood cells and the primary niche (Dehio,2001).  A similar recurrent 
intraerythrocytic bacteremia was seen in rats experimentally infected with B. tribocorum 
(Schulein et al.,2001).    
Unlike, B. bacilliformis and B. quintana, B. henselae uses humans only as incidental 
hosts.  The reservoir for B. henselae is the cat, and the bacteria have been detected in feline 
erythrocytes in vivo and in vitro (Kordick and Breitschwerdt,1995; Mehock et al.,1998; Rolain et 
al.,2001).  Cats are usually asymptomatic, but histopathologic lesions have been reported in the 
spleen, liver and lymph nodes of experimentally infected cats (Guptill et al.,1997).  B. henselae  
may be transmitted to humans via the cat flea or a cat scratch or bite.  Recently, B. henselae was 
detected in human erythrocytes after experimental inoculation raising concerns of possible 
transmission of cat scratch disease through blood transfusion (Pitassi et al.,2007).     
The invasion of erythrocytes by B. bacilliformis has been the subject of many studies 
designed to investigate the severe hemolysis seen during Oroya fever.  While the bacterial 
adhesins responsible for attachment to erythrocytes are unknown, adhesion is energy-dependent 
and is correlated with motility (Benson et al.,1986; Scherer et al.,1993).  The flagella of B. 
bacilliformis were reported to be a virulence factor based on the observation that the number of 
erythrocytes with associated Bartonellae was reduced by 52% after the bacteria were treated 
with anti-flagellar antibodies (Scherer et al.,1993).  The number of bacteria inside of the 
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erythrocytes decreased by almost 100% when the bacteria were pre-treated with anti-flagellar 
antiserum (Scherer et al.,1993).  Non-motile B. bacilliformis showed decreased invasiveness 
(Benson et al.,1986) and B. bacilliformis without flagella were significantly hindered from 
binding to erythrocytes (Battisti and Minnick,1999; Minnick and Anderson,2000).   It is 
unknown whether the motility function is key and/or the flagella themselves participate in 
adhesion.  In addition to B. bacilliformis, B. clarridgeiae, B. schoenbuchensis, B. chomelii, and 
B. capreoli express one to three unipolar flagella (Dehio et al.,2001; Bermond et al.,2002; 
Maillard et al.,2004). The recently described species B. rochalimeae has multiple flagella at one 
pole (Eremeeva et al.,2007).  Of these flagellated species, only B. bacilliformis, B. rochalimeae 
and B. clarridgeiae are known or thought to cause human disease. 
Other virulence factors of B. bacilliformis include the two-gene invasion associated locus 
ialA and ialB which encode a nucleoside polyphosphate hydrolase and an outer membrane 
protein, respectively.  Disruption of ialB caused a decrease in association and invasion of human 
erythrocytes by 47 and 53% (Coleman and Minnick,2001).  Red blood cells do not have an 
active cytoskeleton and therefore cannot phagocytize bacteria.  A secreted protein (or perhaps 
water-soluble molecule) called deformin has been found in B. bacilliformis and B. henselae  
supernatants and may cause invaginations in the blood cell membrane which are then used as 
entry portals by the bacteria (Xu et al.,1995; Iwaki-Egawa and Ihler,1997; Derrick and 
Ihler,2001; Hendrix and Kiss,2003).  As previously mentioned, B. bacilliformis causes 
hemolysis.  The factors involved in hemolysis appear to be contact-dependent and different from 
deformin (Hendrix,2000).  Further evidence that hemolysin and deforming factor are different 
substances comes from the fact that B. henselae did not cause hemolysis but does produce 
deformin (Iwaki-Egawa and Ihler,1997; Hendrix,2000). 
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Agrobacterium tumefaciens, a plant pathogen, is a member of the Rhizobiaceae and is 
related to the Bartonellae (Figure 1).  A. tumefaciens induces tumor formation on plants by 
injecting DNA into plant cells.  The DNA encodes proteins which cause the induction of 
cytokines resulting in proliferation of plant cells and formation of a tumor called Crown Gall 
disease (Backert and Meyer,2006).  The tumor-inducing DNA is injected into the plant by the 
bacteria‟s Type IV secretion system (T4SS) whichis made up of 11 virB/virD proteins.  The 
proteins are assembled into a bacterial inner and outer membrane-spanning channel and an 
extracellular pilus that contacts the plant cell (Zupan et al.,1998).  The T-DNA is translocated 
into the plant cells as a complex with VirD2 protein (Guo et al.,2007). Homologues of the A. 
tumefaciens virB genes were first identified in Bartonella by our laboratory during an 
investigation of an immunodominant 17-kDa protein encoding gene in B. henselae, and we have 
confirmed the presence of the entire operon in B. clarridgeiae ((Padmalayam et al.,2000) and 
unpublished, respectively).   The majority of the Bartonella species, including B. tribocorum, B. 
elizabethae, B. vinsonii and B. quintana also possess the virB operon, while it is not present in B. 
bacilliformis, B. schoenbuchensis, B. chomelii, B. capreoli or B. bovis (Saenz et al.,2007).  Of 
the five species without virB, all except B. bacilliformis possess a virB-like operon (vbh) (Saenz 
et al.,2007), and, interestingly, all except B. bovis are flagellated.  The ancestral B. bacilliformis 
does not have any virB-like genes nor remnants thereof, so apparently the T4SS were acquired 
by the modern-day Bartonella spp. through lateral transfer from other genera (Saenz et al.,2007).    
The role of the VirB system in Bartonella species‟ pathogenesis has been partially 
elucidated.  B. tribocorum virB4 and virD4 mutants failed to cause bacteremia in the rat model.  
It is not clear whether the failure to cause bacteremia was due to the fact that the mutants could 
not invade erythrocytes or because they could not invade the primary niche which seeds the 
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blood invasion (Schulein and Dehio,2002).  The latter explanation appears to be supported by the 
in vitro demonstration that the VirB/VirD4 system is involved in endothelial cell cytoskeletal 
rearrangements leading to internalization of B. henselae, activation of a proinflammatory 
response through NFκB, and inhibition of apoptosis (Schmid et al.,2004).  Unlike A. 
tumefaciens, however, proliferation of host cells is independent of VirB/VirD4 in B. henselae 
infections; a ΔvirB4 B. henselae mutant caused even greater proliferation of human umbilical 
vein endothelial cells (HUVECs) than the vascular endothelial growth factor (VEGF)  control 
(Schmid et al.,2004).  High titers of VirB-positive B. henselae interfered with proliferation and 
were cytotoxic, while ΔvirB4 mutants remained mitogenic at high titers (Schmid et al.,2004). 
The vasoproliferative manifestations of B. bacilliformis, B. henselae or B. quintana 
infection such as veruga peruana and bacillary angiomatosis occur in immunosuppressed or 
immunocompromised individuals.  In the case of B. bacilliformis, the immunosuppression is an 
effect of the first stage of bacterial infection (Bass et al.,1997).  The skin lesions caused by 
Bartonella spp. erupt after a complex series of events beginning with the bacteria coming into 
contact with and entering vascular endothelial cells (Garcia et al.,1992; Koehler,1994; Brouqui 
and Raoult,1996; Dehio et al.,1997; Dehio,1999; Anderson,2001).  Invasion of endothelial cells 
involves different mechanisms than that promoting erythrocyte invasion.  Unlike red blood cells, 
endothelial cells have a dynamic cytoskeleton.  B. bacilliformis causes the rearrangement of 
microfilaments in HUVECs which engulf the bacteria as single cells (Hill et al.,1992).  The 
rearrangement of actin filaments is dependent on Rho GTPase, and activation of Rac and Cdc42 
results in formation of filopodia and membrane ruffles quickly after infection (Verma et 
al.,2000; Verma et al.,2001; Verma and Ihler,2002).  Clumps of B. bacilliformis were seen in 
close contact with the filopodia and lamellipodia.  Inactivation of Rac and Cdc42 results in 
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dramatic decreases in B. bacilliformis internalization (Verma and Ihler,2002).  B. henselae cells, 
on the other hand, are taken up by two methods: en masse in a cytoskeletal structure known as an 
invasome and as individual bacteria by induced phagocytosis (Dehio et al.,1997; Fuhrmann et 
al.,2001; Schmid et al.,2004).   The VirB/VirD4 system is involved in the invasome formation 
(Schmid et al.,2004), but B. henselae is the only known species to enter using that mechanism 
even though other Bartonella spp. have the VirB T4SS.  B. bacilliformis and B. henselae localize 
to the perinuclear region once they enter the endothelial cell and avoid lysosomal degradation 
(Dehio et al.,1997; Verma et al.,2000; Fuhrmann et al.,2001). 
A proinflammatory response mediated by NFκB is induced by B. henselae after 
endothelial cell invasion (Fuhrmann et al.,2001; Dehio et al.,2005).  The subsequent secretion of 
chemokine IL8/CXCL8 and its receptor on endothelial cells suggests that B. henselae can cause 
endothelial cell proliferation in an autocrine manner (McCord et al.,2006).  In addition, IL8 
secretion potentially causes the influx of lymphocytes and macrophages in vivo (Fuhrmann et 
al.,2001; Schmid et al.,2004) making it possible for B. henselae to come in contact with the 
recruited macrophages.  It has been shown in vitro that vascular endothelial growth factor 
(VEGF) and interleukin-1β production are induced in THP-1 macrophages after exposure to B. 
henselae, and conditioned culture medium from infected macrophages can trigger proliferation 
of human microvascular endothelial cells (HMECs) (Resto-Ruiz et al.,2002).  Also, the up-
regulation of  surface adhesion molecules E-selectin and ICAM-1expression by endothelial cells 
is induced by live B. henselae or purified OMPs, an observation indicative of a proinflammatory 
phenotype (Fuhrmann et al.,2001),  In this model, the proliferation of infected endothelial cells is 
part of a paracrine loop in which the angiogenic factors are produced by macrophages rather than 
directly by infected endothelial cells, and the bacteria cause receptors for leukocytes to be 
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produced on the vascular endothelial cell surface.  The study of verruga peruana lesions may 
give more insight into the in vivo process of angiogenesis after infection with Bartonella.  
Angiopoietin-2 (Ang-2) is expressed in endothelial cells in verruga peruana lesions, as are VEGF 
receptor-1 and -2, but VEGF is not (Cerimele et al.,2003).  Angiopoietin-2 expression without 
VEGF expression leads to vessel regression, but Ang-2 together with VEGF form an angiogenic 
signal (Lobov et al.,2002).  The VEGF production necessary for verruga peruana lesions appears 
to come from epidermal cells in vivo, rather than from the endothelial cells (Cerimele et 
al.,2003).  Thus, the two cell types cooperate in angiogenesis. 
B. bacilliformis, B. quintana and B. henselae are capable of stimulating the proliferation 
of endothelial cells directly after contact or through the use of a secreted factor (Garcia et 
al.,1992; Conley et al.,1994; Maeno et al.,1999).  B. bacilliformis cell lysates were found to be 
mitogenic for HUVECs, but B. henselae cell lysates were much less mitogenic (Minnick et 
al.,2003).  Proliferation was inhibited when B. bacilliformis lysates were added at high doses 
without pretreatment.  In contrast, proliferation was induced when the high dose of cell lysate 
was heat-treated before addition to the HUVEC culture (Smitherman and Minnick,2005).  These 
experiments led investigators to conclude that two factors may be involved in B. bacilliformis 
stimulation of endothelial cell proliferation, one of which appears to be a protein.  Further 
experiments with B. bacilliformis suggest that GroEL may be a mitogenic factor or the 
chaperonin for a mitogen (Minnick et al.,2003; Smitherman and Minnick,2005).    In addition to 
proliferation, other characteristics of angiogenesis are endothelial cell migration and formation of 
tubules which then become new vessels.  Both B. henselae and B. quintana stimulate HUVEC 
migration and tube formation in vitro (Conley et al.,1994; Kirby,2004; Dehio et al.,2005). 
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The relative increase in endothelial cell number after infection with Bartonella may be 
due to increased cell division or the inhibition of programmed cell death (apoptosis) or both.  B. 
henselae suppresses activation of the apoptotic proteases caspase 3 and caspase 8 (Kirby and 
Nekorchuk,2002).  The anti-apoptotic activity requires bacterial protein synthesis.  The bacteria 
are not required for inhibition of apoptosis, since conditioned media itself is anti-apoptotic 
(Kirby and Nekorchuk,2002).  This indicates that the anti-apoptotic factor(s) are produced by B. 
henselae in co-culture with HUVECs and that the factor(s) are secreted (Kirby and 
Nekorchuk,2002).  The anti-apoptotic activity of B. henselae requires a functional VirB/VirD 
type 4 secretion system (Schmid et al.,2004). 
Seven effector protein genes designated bepA-G have been identified downstream of the 
virB operon in B. henselae, and the proteins encoded by these genes have been shown to be 
translocated into human endothelial cells via the T4SS (Schulein et al.,2005).  A bepA-bepG 
deletion mutant was unable to invade endothelial cells, did not activate NFκB, and did not inhibit 
apoptosis (Schulein et al.,2005).  BepA was found to be the protein responsible for inhibiting 
apoptosis by inducing the production of a second messenger cAMP (Schmid et al.,2006).  B. 
quintana, B. henselae, and several other Bartonella species have an additional T4SS called Trw 
(Dehio,2008; Nystedt et al.,2008).  A Trw system mutant of B. tribocorum was apparently able 
to colonize the primary niche in the rat model but unable to infect erythrocytes; five days post-
inoculation, the bacteria were found in the blood but no long-lasting bacteremia was established 
(Seubert et al.,2003).  The Trw operon appears to be a recent lateral transfer and duplication of 
genes from a conjugation system of the IncW broad host range plasmid R388 (Frank et al.,2005).  
As Dehio points out, it is interesting to speculate that the Trw system replaced flagella as a 
virulence factor;  with the exception of B. bovis, the species with no Trw genes retained the 
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flagellar system (Dehio,2008).  A third T4SS, the VirB-homologous (vbh) system was 
subsequently reported.  B. tribocorum, B. elizabethae, B. grahamii, B. birtlesii and B. doshiae 
have all three T4SSs (Saenz et al.,2007; Dehio,2008).  B. clarridgeiae has only VirB, and  B. 
bacilliformis has no T4SS (Dehio,2008).  The acquisition of T4SSs and the loss of flagella may 
indicate host adaptation during radial speciation from the ancestral B. bacilliformis to the modern 
Bartonella spp. (Saenz et al.,2007). 
 
Flagella 
B. bacilliformis, B. clarridgeiae, B. schoenbuchensis, B. chomelii, B. rochalimae and B. 
capreoli are currently the only identified Bartonella species that are known to have polar 
flagella.  It is estimated that more than 80% of bacterial species have flagella and use them to 
move through their environment towards or away from particular chemical factors.  These 
factors are sensed by a chemotaxis network which then transmits a signal to the flagellar 
apparatus (Moens and Vanderleyden,1996; Armitage,1999; Thomas et al.,2001).  Flagella are 
helical arrangements of one or more types of flagellin protein that form a flexible, hollow rod.  
Flagella may be arranged peritrichously (several flagella projecting from the entire surface), 
monotrichously (one flagellum at one end; polar) or lophotrichously (two or more flagella at one 
or both ends) on the bacterial cell.  The flagellar motor is driven in some bacteria by a proton 
gradient, and in other genera by a sodium ion gradient.   Although flagella were described before 
1900, most of the knowledge regarding the many parts of the apparatus has been gleaned and 
published since 1970 (Macnab,1999).  Over the past 30 years, investigators have found more 
than 50 genes involved in the biosynthesis of flagella (Macnab,2004).  The major parts of the 
flagellar structure are the basal body that spans the cytoplasmic and outer membranes, the rod, 
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the exterior hook and the flagellar filament (Macnab and DeRosier,1988; Macnab,1999; Bardy et 
al.,2003; Macnab,2003).  The sequential expression and assembly of the flagellar apparatus 
begins with the formation of the proximal basal body with its integral cytoplasmic membrane M 
and S rings and ends with the distal filament (Macnab and DeRosier,1988; Macnab,2003; 
Macnab,2004).  In order to assemble the structure in the proper sequence, the flagellar 
biosynthesis genes are expressed in a hierarchical manner that proceeds through three or four 
classes of genes, depending on the organism.  In the 4-class system (represented by Caulobacter 
crescentus), class I consists of ctrA, a gene encoding a transcription factor that is essential for 
expression of class II genes (Champer et al.,1985; Champer et al.,1987).  Class II genes include 
the components of the basal body (MS ring, motor, switch, and flagellar Type III secretion 
system) and transcription factors flbD and rpoN which are required for expression of the next 
class of genes (Boyd and Gober,2001).  Once the basal body is synthesized, Class III genes are 
the next to be expressed and include the rod and hook (Ohta et al.,1985).  The flagellin genes are 
the last to be expressed, and their transcription depends on the prior assembly of the hook 
structure (Anderson and Gober,2000). In E. coli, there are 3 classes of genes in the flagellar 
hierarchy. Class I consists of the master regulator operon flhDC.  FlhD2C2 is a transcriptional 
activator of Class II genes which includes an operon containing a flagellum-specific sigma factor 
σ28encoded by the fliA gene, the flhB operon (part of the type III secretion system) and the fliL 
operon (which encodes cytoplasmic membrane proteins of the basal body) (Liu and 
Matsumura,1994).   
E. coli and Salmonella flagellar biosynthesic mechanisms have been particularly well 
studied.  In an elegant set of experiments, Jones and Macnab deduced much of the assembly 
order in Salmonella enteric serovar Typhimurium by use of temperature sensitive mutants (Jones 
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and Macnab,1990).  The assembly of the flagellum begins with the most proximal structure 
known as the basal body.  The basal body consists of the MS ring which has two parts but is 
made of 24-26 subunits of one protein, FliF(Thomas et al.,2006).  FliG, the switch protein of the 
cytoplasmic C-ring is assembled after FliF is integrated into the cytoplasmic membrane(Francis 
et al.,1992) followed by FliM and FliN.(Kubori et al.,1997).  FliE has been described as both a 
basal body protein and a rod protein because it probably lies on the distal face of the MS ring at 
the proximal end of the rod (Macnab,2003).  The MS ring is assembled in the bacterial 
cytoplasmic membrane by the Sec general export pathway probably at the same time that the 
flagellar type 3 export apparatus is assembled within the MS ring (Macnab,2003).  The flagellar 
export apparatus, which is involved in the translocation of many of the flagellar proteins to the 
outside of the cytoplasmic membrane, has at least 6 proteins integrated into the membrane 
including FlhA, FlhB, FliO, FliP, FliQ and FliR (Macnab,2003).  Substrates to be exported dock 
on the inner surface where the ATPase (FliI), its regulator (FliH), and chaperone protein (FliJ) 
are located (Thomas et al.,2004; Stafford et al.,2007).  The substrates are sorted so that early rod 
and hook proteins are exported before the later hook and filament proteins(Stafford et al.,2007).  
The sorting and export depend on N-terminal signals on the exported proteins (Stafford et 
al.,2007).  All proteins residing outside of the cytoplasmic membrane, except the P and L rings, 
are exported via the flagellar T3SS (Macnab,2004). 
The rod spans the cytoplasmic and outer membranes, and the proximal portion of it is 
made of a helical arrangement of protein subunits FlgB, FlgC, and FlgF  (Homma et al.,1990).  
Another protein, FlgJ is essential for rod formation (Kubori et al.,1992).  At the C-terminus of 
FlgJ is a muraminidase domain that may be involved in digesting the peptidoglycan layer for the 
protruding rod (Macnab,2003).  A second proposed function of FlgJ is as a rod capping protein 
 19 
 
(Hirano et al.,2001).  Experiments indicate that both of the two possible functions of FlgJ could 
be correct and may be attributable to the C- and N-termini, respectively (Hirano et al.,2001).  
The last protein of the rod structure is FlgG, and it lies at the rod-hook junction.  It is not known 
how the rod length is determined. 
The L and P ring proteins are exported via the Sec pathway and assemble around the 
rod„s circumference (Homma et al.,1987; Jones et al.,1987; Jones et al.,1989). The P ring 
surrounds the rod in the periplasmic space and is made of FlgI.  The L ring, FlgH, a lipoprotein, 
is located in the outer membrane.   
The next substructure to be assembled is the hook.  FlgE is the single hook protein in 
Salmonella, and the protein subunits are exported through the lumen of the rod and growing 
hook.  As the hook assembly begins, the rod capping protein is replaced by a hook cap, FlgD 
(Ohnishi et al.,1994).  The hook is not correctly assembled unless the hook capping protein, 
FlgD, is present (Suzuki et al.,1978; Suzuki and Komeda,1981).  A flgD mutant was found to 
secrete FlgE in to the culture media (Ohnishi et al.,1994).  When the length of the hook reaches 
about 55nm, hook assembly stops.  FliK is the hook length control protein and it is exported 
during hook assembly (Minamino et al.,1999).  The mechanism for producing a hook of the 
proper length is still unknown.  Makishima et al. proposed a model in which the C ring acts as a 
measuring cup that holds 120 hook subunits(Makishima et al.,2001).   FliK mutants produce 
elongated hooks with no filament (Muramoto et al.,1999).   Recently, Moriya et al. proposed that 
FliK acts as a “ruler” with proper hook length being dependent on FliK and on the hook 
polymerization rate (Moriya et al.,2006).   When the hook reaches the desired length, the 
flagellar T3SS switches to export late flagellar substrates including hook-associated proteins 
(HAPs) FlgK, FliD, and FlgL (Williams et al.,1996; Minamino and Macnab,1999; Hirano et 
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al.,2003).  The change of substrate specificity is dependent on FlhB which is some how 
associated with the hook length protein FliK (Ferris and Minamino,2006).  FliD replaces FlgD 
and remains with the growing filament as its cap protein. 
The final structure to be assembled is the filament which is composed of flagellin protein.  
Some flagella filaments contain over 20,000 flagellin subunits.  The flagellin proteins are 
exported through the hollow filament and are added one by one to the distal end of the growing 
structure.  The filament cap, FliD, may act as a scaffolding to orient the incoming flagellin 
subunits, but it also acts more like a filter than a stopper, since some proteins such as FlgM, the 
anti-sigma factor, continue to be exported from the flagellum (Chilcott and Hughes,2000). 
The flagellar motor in E. coli consists of a stator made of MotA and MotB, perhaps 
which is believed to contain 4 MotA subunits and 2 MotB subunits (Khan et al.,1988).  MotA 
has four transmembrane domains, and the cytoplasmic domain has two charged residues that are 
important for rotation (Zhou and Blair,1997).  Most of MotB is in the periplasmic space and the 
C-terminal region attaches to the cell wall (Muramoto and Macnab,1998).   The rotor/switch 
complex is made of FliG, FliM and FliN which controls rotation and the direction of rotation 
(Yamaguchi et al.,1986; Yamaguchi et al.,1986).  In E. coli and some other bacteria, the flagella 
turn in both the clockwise and counter-clockwise direction (Khan and Macnab,1980; Macnab 
and Han,1983; Yamaguchi et al.,1986; Gotz and Schmitt,1987; Cohen-Ben-Lulu et al.,2008).  
Counter-clockwise rotation results in swimming and clockwise rotation causes tumbling 
(Macnab and Han,1983).  The default direction is counter-clockwise (Harshey and 
Toguchi,1996).  When the bacterial cell encounters attractants or repellents that bind to methyl-
accepting chemotaxis proteins on the cell membrane, a signal is recognized by CheA-CheW 
(Armitage,1999).  The response regulator CheY is then phosphorylated (Armitage,1999).   
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CheY, in its phosphorylated state, binds to FliM and causes a change in rotational bias from 
counter-clockwise to clockwise (Sanders et al.,1989; Bren and Eisenbach,2001). Other bacteria 
have unidirectional flagellar rotation, usually counter-clockwise.  However, alpha-proteobacteria 
with polar flagella such as Sinorhizobium meliloti display clockwise rotation and have two CheY 
regulators (Scharf and Schmitt,2002).  CheY2 regulates the speed of the motor, and CheY1 acts 
as a sink for phosphoryl groups from CheY2 (Scharf and Schmitt,2002).  The speed variation 
depends on two additional motor proteins MotC and MotE (Platzer et al.,1997; Eggenhofer et 
al.,2004).  Both MotC and MotE are periplasmic.  MotC binds MotB and regulates the proton 
channel (Scharf and Schmitt,2002).  MotE is the chaperone for MotC (Eggenhofer et al.,2004).  
The MotD protein was originally believed to be part of the motor mechanism because mutations 
in motD resulted in a non-motile cell(Platzer et al.,1997).  However, later studies indicated that 
MotD was the hook length control protein and as a consequence was renamed as FliK 
(Eggenhofer et al.,2006).  Several models have been proposed for the mechanism of torque 
generation, but none has been confirmed (Kojima and Blair,2004). 
The regulation of flagellar gene expression and protein assembly is as complex as the 
structure itself.  In all bacterial flagellar systems examined, production of flagellar components is 
regulated by a hierarchical cascade of gene expression in which expression of one class of genes 
does not take place until expression of a preceding class.  The expression of the first class, the 
master regulator, is induced by environmental factors as well as internal signals.   Expression of 
flhDC has been shown to be linked to the cell cycle with expression at its lowest point during cell 
division (Pruss and Matsumura,1996; Pruss et al.,1997; Pruss and Matsumura,1997).  Likewise, 
activity of CtrA in C. crescentus is regulated by the cell cycle (Quon et al.,1996; Domian et 
al.,1999)  Cyclic AMP-catabolite activator protein has been shown to activate flhDC expression, 
 22 
 
and histone-like nucleoid-structuring protein H-NS represses flhDC expression in E. coli 
(Soutourina et al.,1999).  FlhDC production is also influenced by temperature, pH and oxygen 
levels (Li et al.,1993; Shi et al.,1993; Liu et al.,2000; Soutourina et al.,2001). In one study,  
acetyl-phosphate levels in the cell increased during increased osmolarity as did phosphorylated 
OmpR, a protein involved in osmoregulation (Shin and Park,1995).  The authors found that 
OmpR-P bound to the flhDC promoter and inhibited transcription (Shin and Park,1995).  
However, subsequent studies did not confirm that finding (Kutsukake,1997).  Particular 
mutations in heat shock protein genes dnaK, dnaJ or grpE resulted in non-motile E. coli due to a 
lack of flagellin production (Shi et al.,1992).  Specific mutations in other heat shock proteins, 
namely groEL140 and groES30, did not cause a loss of motility (Shi et al.,1992).  
Transcriptional fusions indicated that the dnaK mutant strain had decreased transcription of flhD 
and fliA, which encodes σ28, the flagellar sigma factor (Shi et al.,1992).  When σ28  is low, flhDC 
expression is low (Kutsukake,1997).  It may be that feedback mechanisms exist in bacteria to 
turn off the energy-expensive production of flagella during times of stress. 
Sigma-28 RNA polymerase is also a critical part of the regulatory system for the 
expression of class III flagellar genes (Ohnishi et al.,1990).  FlgM is an anti-sigma factor that 
binds sigma-28 during the assembly of the basal body and hook (Hughes et al.,1993).  Once the 
basal body and hook are completed, FlgM is exported through that structure and σ28 is free to 
promote the transcription of the flagellin, motor and chemotaxis protein genes in class III.  
Master regulators and flagellar-specific sigma factors have been found in many bacterial genera 
possessing lateral or polar flagella and some organisms such as V. alginolyticus possess both 
types of flagella with their respective regulatory systems and flagellar motors (Atsumi et 
al.,1992; Kawagishi et al.,1996). 
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Two-component regulators have been found to regulate flagellar production.  A 
transcriptional regulator, VjbR, a protein involved in quorum sensing in Brucella melitensis 
regulates expression of virB and flagellar genes (Delrue et al.,2005).  A vjbR mutant was greatly 
attenuated in the mouse model (Delrue et al.,2005). 
 
Flagella and Virulence 
The degree of association between flagella and virulence is controversial and may be 
species- or even strain-specific.  Motility helps bacteria reach the area or organ they ultimately 
colonize.  For example, motility was required in Burkholderia cepacia for invasion of cultured 
epithelial cells (Tomich et al.,2002);  In addition, Campylobacter jejuni need flagella 
(specifically FlaA) to pass the gastrointestinal tract,  and anti-flagellar antibodies reduced 
colonization (Ueki et al.,1987; Wassenaar et al.,1993) A flaAflaB double mutant of Helicobacter 
mustelae was unable to colonize a ferret model of infection and a flbA mutant of H. pylori was 
non-motile and unable to colonize gerbils (McGee et al.,2002).   In some bacteria, expression of 
flagellin proteins undergoes phase variation, and the change in flagellin antigen expression aids 
in evading host immune responses (Nuijten et al.,1995; Ikeda et al.,2001; Bonifield and 
Hughes,2003).  Flagella have also been shown to be involved in adherence of bacteria to 
mammalian cells.  For example, adherence to mouse cecum was 10-fold lower in non-flagellated 
Clostridium deficile strain (Tasteyre et al.,2001) while Aeromonas strains lacking polar flagella 
failed to adhere to enterocytes in culture and showed a decreased ability to form biofilms (Kirov 
et al.,2004).  Further involvement in virulence has been proposed for the flagellar systems of 
Campylobacter jejuni, Yersinia enterocolitica and Helicobacter pylori.  In C. jejuni, secretion of 
the virulence factor CiaB is dependent on a functional flagellar apparatus (Konkel et al.,2004).  
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FlaC secretion requires a minimal flagellar structure, and invasion of a C. jejuni flaC mutant was 
reduced to 14% of the parental strain (Song et al.,2004). The phospholipase YplA was found to 
be exported by the flagellar T3SS in Y. enterocolitica (Young et al.,1999; Young and 
Young,2002).  And in H. pylori, FlbA, a protein involved in flagellar biosynthesis, has been 
shown to modulate urease activity and is required for motility and virulence(McGee et al.,2002).    
 
Bartonella with Flagella 
The flagellum of B. bacilliformis is a virulence factor for the organism as indicated by the 
observation that antiflagellar antibodies reduced attachment and invasion of B. bacilliformis into 
human erythrocytes (Scherer et al.,1993). The hallmark of B. bacilliformis infection in humans is 
severe hemolytic anemia (Anderson and Neuman,1997).  Even though B. clarridgeiae possess 
flagella and has been isolated from cat blood, most cats infected with B. clarridgeiae do not 
show many overt signs or symptoms of disease and none has been documented with severe 
anemia (Kordick et al.,1995; Kordick et al.,1999).  Therefore, it seems likely that if B. 
clarridgeiae invades red blood cells, it does not damage them and may reside intracellularly 
while replicating in other types of cells.  While phenotypically similar to B. bacilliformis, the 
route of infection and the symptoms of B. clarridgeiae infection in humans more closely 
resemble those of B. henselae, a non-flagellated species.  These findings prompted us to ask: is 
B. clarridgeiae capable of invading human endothelial cells and is motility a requirement for 
invasion of host cells by B. clarridgeiae?   
To investigate the role of flagella in B. clarridgeiae pathogenesis, we sought to separate 
motility from any other function flagella may have.  Depending on the hierarchy of B. 
clarridgeiae's flagellar genes, a site-specific mutation in a gene(s) encoding a flagellar motor 
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protein(s) may render the organism non-motile while still allowing flagellar biosynthesis.  The 
flagellin gene flaA in B. clarridgeiae has been sequenced (Sander et al.,2000), but other genes in 
the flagellar regulon of B. clarridgeiae have notbeen published or released by GenBank.  In this 
study we determined the sequence of the flagellar motor genes motBC of B. clarridgeiae and 
created a single site-specific mutation interrupting both motB and motC.   A similar method was 
used to create a mutation in flaA.  The motBC mutant was non-motile but flagella were seen by 
electron microscopy.  The flaA mutant was void of flagella and was non-motile.  The flaA and 
motBC mutants and wild-type B. clarridgeiae were tested for their ability to invade HMECs in 
vitro, and the proteins secreted by the three strains and the HMECs were analyzed.  We report 
that B. clarridgeiae 1) does not require a flagellar structure to invade endothelial cells; 2) enters 
endothelial cells as single bacteria rather than in a large mass; and 3) causes proliferation of 
endothelial cells.  In addition, the wild-type bacteria, flaA and motBC mutants have different 
effects on HMECs as demonstrated by protein secretion.   
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CHAPTER I 
Site-specific Mutagenesis of Flagellar Genes in B. clarridgeiae 
 
Introduction 
Many species of bacteria possess flagella and use them as  propellers to move towards 
favorable environmental conditions (Macnab and Aizawa,1984).  In E. coli, the concentration of 
attractant or repellent in the environment is sensed by the bacterium through exposed methyl-
accepting chemotaxis proteins which transduce a signal to internal chemotaxis proteins.  The 
signal is then relayed to the flagellar motor which drives the helical flagellar filament (Scharf 
and Schmitt,2002).  The flagellar motor in most bacteria is fueled by a protonmotive force 
created by a proton gradient across the inner membrane (Macnab,1986).  The stator of the 
flagellar motor appears to be made of a ring of only two proteins, MotA and MotB, in E. coli, 
with a ratio of MotA to MotB reported to be MotA4MotB2 (Berg,2003).  The MotB protein is 
predominantly in the periplasm and has a peptidoglycan binding domain.  Therefore, MotB 
serves as an anchor as well as proton channel (Kojima et al.,2008).  Exactly how the motor 
works is undetermined, but one proposed mechanism hypothesizes that the protonmotive force 
induces conformational changes in MotB which applies force to the rotor protein 
FliG(Blair,2003).  The rotor turns the rod and the hook which causes the filament to spin. 
In a close relative of B. clarridgeiae, Sinorhizobium meliloti, two additional mot genes 
were discovered downstream from motB (Platzer et al.,1997).  MotC encodes a putative  434 
amino acid protein, and MotD is predicted to be 475 amino acids in length (Platzer et al.,1997).  
MotC was found in the periplasm and MotD was thought to be located in the cytoplasm.  
Mutants in motB, motC or motD were non-motile but had intact flagella (Platzer et al.,1997).  
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Complementing motB or motC did not completely restore motility, but the motD deletion mutant 
regained complete motility when motD was provided in trans (Platzer et al.,1997).   The authors 
postulated that the correct stoichiometry of MotB and MotC was necessary for controlling the 
speed of flagellum rotation (Platzer et al.,1997).  Originally, no known function was attributed to 
MotD; however, several years after the original description, other investigators concluded that 
MotD was actually FliK, the hook-length control protein (Eggenhofer et al.,2006).  A knock-out 
mutant in motD resulted in variable flagellar hook lengths, typical of fliK mutations, which cause 
the cell to be paralyzed. 
B. clarridgeiae has been shown to produce polar flagella (Clarridge et al.,1995; 
Collins,1996).  Antibodies made against B. bacilliformis  flagellar filaments inhibited the bacteria 
from invading erythrocytes (Scherer et al.,1993). Similarly, whole cell antibody raised against a 
crude cell wall preparation from B. bacilliformis  blocked the organism‟s entry into HUVECs 
(Hill et al.,1992).  It is not known whether B. clarridgeiae is able to invade human endothelial 
cells, but invasion would be a likely requirement in order to produce the Cat Scratch disease-like 
symptoms that have been attributed to the organism.  Also, if B. clarridgeiae is capable of 
invading endothelial cells, are flagella required?  Do the flagella of B. clarridgeiae function only 
as a means of locomotion?  In order to address these questions, we sought to separate the 
function of motility from any other function flagella may have by creating non-motile mutants 
with and without intact flagella by insertional mutagenesis of flagellar motor genes and the 
flagellin gene, respectively.  We then compared the ability of these mutants to invade human 
endothelial cells with that of the wild-type B. clarridgeiae. 
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Materials and Methods 
 
Bacteria.  B. clarridgeiae type strain ATCC 51734 was grown for 5 days on heart infusion agar 
with 5% rabbit blood (HIA-RB) at 37°C and 5% CO2.  B. clarridgeiae mutants were grown on 
HIA supplemented with kanamycin (50μg/ml).  E. coli was grown overnight at 37°C on Luria 
Bertani (LB) agar.  Bacterial strains and plasmids used are listed in Table 1. 
 
Table 1.  Bacterial Strains and Plasmids 
Strain or plasmid Relevant characteristics Source or reference 
Bartonella clarridgeiae 
 ATCC 51734 
T
 
a.k.a.,Houston-2 cat ATCC 
E. coli XL2 Blue Host strain for cloning Stratagene 
pBBR1MCS-2 RepEC,RepBb,Km
r
 ME Kovach 
(Kovach et al.,1995) 
pPCRscript Cloning vector, RepEC,Ap
r
 Stratagene 
pBCmotBAmp pPCRscript  containing 480bp SmaI-
SacI fragment of motBC 
This study 
pBCmotBKan pBCmotBAmp cut with BspHI and 
bla (Amp
r
) removed and replaced with 
1700bp nptI Km
r
 fragment from 
pBBR1MCS-2. 
This study 
pBCflaAAmp pPCRscript  containing 1000bp 
BamHI-SacI fragment of flaA 
This study 
pBCflaAKan pBCflaAAmp cut with BspHI and bla 
(Amp
r
) removed and replaced with 
1700bp nptI Km
r
 fragment from 
pBBR1MCS-2. 
This study 
 
Transposon mutagenesis.  B. clarridgeiae was harvested from HIA-RB plates and suspended in 
1ml heart infusion broth at room temperature.  The suspension was centrifuged at 2900 x g for 
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5min at 4 C.  The pellet was washed in ice-cold 10% glycerol and centrifuged again.  The loose 
pellet was resuspended in 1ml 10% glycerol.  One microliter of EZ::TN <Kan-2> Tnp 
transposome (Epicentre Biotechnologies, Madison, WI) was added to 40 l B. clarridgeiae 
suspension undiluted, diluted 1:1, diluted 1:3 or diluted 1:7 in 10% glycerol.  The reactions were 
iced for 15min then transferred to iced cuvettes (2cm, Bio-Rad).  The cells were electroporated at 
12.5kV/cm (2.5kV), 25 F capacitance, and 200 ohms.  One milliliter of trypticase soy broth was 
added to each cuvette, and then the suspension was poured on an HIA-RB slant and incubated 
overnight at 37 C, 5% CO2. After 23hr the broth appeared cloudy.  Aliquots of the culture were 
plated on HIA-RB plates containing kanamycin at 50 g/ml.  The plates were incubated 
overnight.  After 12 hours of incubation, the plates were examined for growth.   
 
Test for motility.  Transparent agar was prepared by a modification of the method of Benson et 
al. (Benson et al.,1986).  Briefly, rabbit blood was lysed by mixing 1 volume of outdated rabbit 
blood with 3 volumes of deionized water.  The mixture was shaken gently to lyse the cells and 
then centrifuged at 3000 x g for 15 min at 4 C to remove debris.  The supernatant was retained 
and added to Heart Infusion broth at a final concentration of 5% vol/vol.  Motility agar plates 
were prepared by adding agar to HIB-RB lysate at a final concentration of 0.35%.   Single 
colonies of bacteria were picked from plated media with a sterile toothpick and stabbed into the 
motility agar.  The motility agar plates were incubated without inversion for 5 days at 37°C with 
5% CO2. 
DNA purification.  DNA was purified from bacteria using a Qiagen QIAampDNA mini kit 
(Valencia, CA) as per the kit protocol and eluted with 200 l PCR grade water (APEX 
Bioresearch Products distributed through DocFrugal Scientific, San Diego, CA). 
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Sequencing.  DNA sequencing was performed on B. clarridgeiae transformant genomic DNA 
using an ABI Prism Big Dye dye terminator kit (Foster City, CA) and primers supplied with the 
EZ::TN <Kan-2> transposon kit.  Sequencing reactions were purified through Centri-Sep 
columns (Princeton Separations, Princeton, NJ) and electrophoresed through a 50cm capillary 
array filled with POP-6 polymer using an ABI 3100 automated capillary sequencer.  Sequences 
were analyzed using a UNIX operating system and Wisconsin Package version 10.2 (Genetics 
Computer Group, Madison, WI). 
 
Genomic DNA library construction.  Four genomic DNA libraries were made from B. 
clarridgeiae wild-type DNA according to the instructions included in the Genome Walker 
Universal Kit (Clontech, Mountain View, CA).  The flaA region was amplified using primers 
supplied in the kit and flaF122 or flaR1125 (Table 2).  Amplicons were sequenced using flaF122 
and flaR1125 and additional primers that were designed as sequence was elucidated (see Table 
2). 
 
Site-directed mutations in flaA and motBC.  To generate a suicide vector, a 1025-bp fragment 
of the 1200-bp flaA gene was amplified using primers using primer SmaflaAF and SacflaAR and 
ligated into the PCRscript plasmid previously digested with restriction enzymes Sma and Sac 
and purified.  PCR script contains the pMB1 replication origin which functions in E. coli but 
does not function in Bartonella.  A selectable marker, the kanamycin-resistance gene (nptI), was 
amplified from plasmid pBBR1MCS-2 and ligated into the flaA suicide plasmid. A single 
crossover recombination event would produce a Kan-resistant strain with an interrupted flaA 
gene.   
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A similar plasmid was constructed to disrupt flagellar motor genes motBC.  The DNA 
sequences of the motB and motC genes were determined in this study.  The PCRscript plasmid 
with the nptI gene was ligated to a 460-bp DNA fragment that comprises the 3‟ terminus of motB 
and the 5‟ end of motC from B. clarridgeiae. 
In order to make large scale plasmid stocks, the suicide vectors were first electroporated 
into E. coli.  Plasmid preparations were made from individual kanamycin-resistant colonies 
subsequently grown in LB broth.  B. clarridgeiae was electroporated with the purified plasmid 
DNA and plated on HIA-RB containing 50mg/ml kanamycin. Individual kanamycin-resistant 
colonies were picked and passed to fresh HIA-RB-Kan plates. 
 
DNA and protein sequence analysis.  DNA sequences were analyzed using the GCG (Accelrys, 
Transmembrane regions and signal peptides were predicted by the program Phobius (Kall et 
al.,2007). 
 
HMEC invasion assay.  CDC.HMEC-1 (CDC, Atlanta, GA.) human microvascular endothelial 
cells were grown at 37
o
C and 5% CO2 using MCDB-131 (GIBCO, Invitrogen, Carlsbad, CA) 
media supplemented with 10% fetal bovine serum (Hyclone, Ogden, UT) and 2mM L-glutamine 
(GIBCO, Invitrogen, Carlsbad, CA).  Cells were seeded at 1.5x10
5
/mL.  HMECS with passage 
number below 16 were used in invasion assays.  HMECs were grown to 80% confluency and 
inoculated with Bartonella at HMEC cell to bacteria ratios of 1:10, 1:30 or 1:100.  
 
Transmission electron microscopy.  Human microvascular endothelial cells (1.5x10
5
/ml) were 
infected with B. clarridgeiae wild-type, the flaA mutant or the motBC mutant at multiplicity of 
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infection (MOI) of 100.  After 5 days, the medium was removed and the cells were washed once 
with phosphate buffered saline, pH 7.4 (PBS).  The cells were fixed with Karnovsky‟s fixative 
(Electron Microscopy Sciences, Hatfield, PA) for 1 hour before a second wash with PBS.  The 
flasks were stored at 4°C in PBS until processed for transmission electron microscopy.   
 
Phase contrast microscopy.  Human microvascular endothelial cells (1.5x10
5
/ml) in 6-well 
tissue culture dishes were infected with B. clarridgeiae wild-type, the flaA mutant or the motBC 
mutant at MOIs of 10, 30 or 100 and viewed under a phase contrast microscope (Zeiss) at 1 to 6 
days post-infection to assess endothelial cell proliferation and bacterial attachment. 
 
Confocal microscopy.  HMECs grown on sterile coverslips and infected with Bartonella or 
uninfected were permeabilized at 1 to 5 days post-infection with TritonX100 and then stained.  
HMECS were treated with propidium iodide to stain dead bacteria red (Baclight kit, Invitrogen, 
Carlsbad, CA) and Alexa 488 phalloidin (Invitrogen, Carlsbad, CA) which stains F-actin green.   
 
Gentamicin protection assay.  HMECS were inoculated with Bartonella at an MOI of 30.  
After 1, 3, or 5 days, the cultures were treated with gentamicin (250µg/ml) to kill extracellular 
Bartonella.  The cells were washed twice with media to remove the gentamicin, and the HMECs 
were lysed with 1% saponin in PBS to release the intracellular organisms.  Cell lysates were 
serially diluted and plated on HIB-Rb agar.  The number of intracellular bacteria was compared 
to lysed cells that had not been treated with gentamicin (intracellular and extracellular bacteria).  
Medium from gentamicin-treated cultures was also plated on agar to test for sensitivity of the 
bacteria to the antibiotic.  Each experiment was conducted three or more separate times. 
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Table 2.  PCR and Sequencing Primers 
Name Sequence 5‟ to 3‟ Gene target 
flaF122 TGT TTC GAC AGG TTT GCG TAT CAG flaA 
flaR1125 GCA AGG CAG CCA ACT TAG CAG flaA 
flaA1452R GCC GAT TGA ACT GCA TTA GAA flaA 
flaA1516R ATA CCC TGC TGC CAT ACC AAC flaA 
flaA1977F TGG CGA GTT ACA TTC AGA CAT flaA 
flaA2074F ATT GGA GCC GCT GTT AAT TTG flaA 
flaA3144F GGG TAA GAG CAG TGG CGA TTT flaA 
BspHI-U23751Fa AAA TCA TGA CCG GAA GCA TAA AGT GTA AAG C nptI 
BspHI-U23751R AAA TCA TGA GCC TGA AGC CCG TTC TG nptI 
SMAflaAF AAA CCC GGG TGT TTC GAC AGG TTT GCG TAT CAG flaA 
SACflaAR AAT GAG CTC GCA AGG CAG CCA ACT TAG CAG flaA 
SMAMOTBF AAA CCC GGG CTA TTC CGA CGG CGC AGA C motBC 
SACMOTBR AAT GAG CTC GAA GCC CTT CCT TGT TGC ATA AGA motBC 
MotB21F TAT GAG TTT CCG AAA GA motBC 
MotB639F GGA GGA CAT GGC GAT CA motBC 
MotB639R TGA TCG CCA TGT CCT CC motBC 
MotB1255F ATA TAT TGG CCC ATG TG motBC 
MotB1255R CAC ATG GGC GAA TAT AT motBC 
MotB1809F AAC AAG GAA GGG CTT CT motBC 
MotB1809R AGA AGC CCT TCC TTG TT motBC 
MotB2443F TTT GGC CTT ATT AGT TC motBC 
MotB2515R CTG TAA TAT AGC GGG AGT AAA T motBC 
MotB3037R GTG CGA GAG AAT GTT TGT CTA C motBC 
a 
restriction enzyme recognition sequence 
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Proliferation assay.  HMECs in flat-bottom culture plates were not infected, infected with B. 
clarridgeiae wild-type, the B. clarridgeiae flaA mutant or the B. clarridgeiae motBC mutant.  
Proliferation was assessed using the MTT ((3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) cell proliferation assay according to the manufacturer‟s 
instructions (Roche).   In similar experiments, to eliminate the possibility of bacteria interfering 
with the MTT assay, the HMECs were treated with gentamicin (250µg/ml) to kill extracellular 
bacteria, washed and then treated with MTT for 4 hours at 37 C with 5% CO2.  After the MTT 
treatment, solubilization solution was added to the cells and the plates were incubated overnight 
at 37 C with 5% CO2.  The plates were read in a scanning spectrophotometer at 530nm.  Each 
sample parameter was tested in 8 wells, and three or more experiments were run separately. 
 
Cytotoxicity assay.  The cytotoxic effect of Bartonella infection was quantitated based on the 
measurement of lactate dehydrogenase activity in the supernatant of microtiter plate wells 
containing HMECs and Bartonella.  The HMECs were inoculated with Bartonella at an MOI of 
10, 30 or 100.  At certain time points, 100µl of each supernatant was combined with 100µl of 
assay buffer, and the absorbance was measured.  Triton X-100 treated HMECs were used as the 
positive high control, and cell culture medium alone was used as the negative low control.  Each 
sample parameter was tested in 8 wells, and three or more experiments were run separately. 
 
Results 
 
B. clarridgeiae flaA gene region sequence analysis.  The flaA gene sequence of B. clarridgeiae 
has been previously published (Sander et al.,2000).  Primers designed from that sequence (Table 
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2) were used to sequence the DNA surrounding the  flaA gene to determine if flagellar genes 
were in a flagellar operon such as is found in A. tumefaciens.  A 3415-bp region surrounding and 
including the 1260-bp flaA gene was sequenced.  In B. clarridgeiae, flaA was found to be 
located between proC (pyrroline-5-carboxylate reductase) and etfD (electron transfer 
flavoprotein-ubiquinone dehydrogenase).  This gene arrangement is identical to that of B. 
bacilliformis (GenBank accession number for genome sequence NC_008783).  In B. henselae the 
gene between proC and etfD is a phage-related protein (GenBank accession number 
NC_005956), and B. quintana has neither a phage related gene nor flaA between proC and etfD 
(NC_005955).  In A. tumefaciens, the genes surrounding flaA are all flagellar related 
(NC_003062) (Figure 2). 
 
Non-motile mutants created by transposon mutagenesis.  Attempts to amplify the B. 
clarridgeiae motB gene using primers derived from the A. tumefaciens or S. meliloti motB 
sequence were unsuccessful.  At the time, the B. bacilliformis motB and genome sequences were 
not available.  In order to find the flagellar motor genes, B. clarridgeiae strain ATCC 51734
T
 
was mutagenized by random transposon mutagenesis, and non-motile mutants were identified on 
semi-soft agar.   The Tn5 insertion site for each of 18 non-motile transformants was determined 
by sequencing the surrounding DNA using the transposon-specific primers supplied with the 
transposon kit.  The sequences of three flagellar-related genes had been interrupted by 
transposons in one or more mutants: motB, motC and fliF.  FliF is the protein that makes up the 
entire MS ring of the flagellar basal body and is in the second class of genes in the flagellar 
assembly hierarchy of most bacteria.  Because a fliF mutant would interrupt the flagellar 
assembly at an early stage, it was not investigated further.  A motB or motC motor mutant, 
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however, should have an intact flagellum and be paralyzed because of the faulty motor.  Primers 
derived from the motB and motC sequences around the transposon were used to amplify a larger 
portion of B. clarridgeiae genomic DNA in genome walker libraries.  Through primer walking, 
3792 base pairs of DNA sequence including the full length gene sequences of motB and motC 
and the partial sequence of another flagellar gene (motD) were determined.   
 
 
Figure 2.  Gene arrangement surrounding flaA in B. bacilliformis, B. clarridgeiae, B. henselae, 
B. quintana and A. tumefaciens.  Order of genes in B. clarridgeiae (Bc), B. bacilliformis (Bb)  B. 
henselae (Bh), B. quintana (Bq), and A. tumefaciens (At) determined from genome sequence. 
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Figure 3.  Alignment of MotB protein sequences.  Brucella melitensis (Br.m) GenBank accession 
number AAL53395, Brucella suis (Br.s) GenBank accession number AAN34303, Ohrobacter 
anthropi (Oa) GenBank accession number ABS16898, B. bacilliformis (Bb) ABM44931 and B. 
clarridgeiae (Bc).  The transmembrane region is indicated by a parallelogram above the 
sequence, and the OmpA-like region is underlined. 
The motB gene was found to be 1065bp long and encoded a 355 amino acid protein.  The 
N-terminal region was predicted to reside in the cytoplasm, and one transmembrane region with 
an alpha helix was predicted (Geneious).  The final third of the polypeptide contained a 97-aa 
OmpA-like sequence which corresponds to the putative polysaccharide-binding portion of the 
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protein.  There was 60% similarity over the 357aa shared by B. bacilliformis and B. clarridgeiae 
motB, and B. clarridgeiae and Brucella melitensis motB proteins were 42% similar.  The OmpA-
like domain of the B. clarridgeiae motB sequence was 83% and 65% similar to the 
corresponding domain in the MotB of B. bacilliformis and B. melitensis, respectively.  When the 
MotB proteins of B. clarridgeiae, B. bacilliformis, B. melitensis, B. suis and Ochrobacter 
anthropi were aligned, 17 of the 21 amino acids in the predicted transmembrane region were 
completely conserved, and 61 of the 97 residues of the OmpA-like region were identical (Figure 
3). 
The gene identified as motC in B. clarridgeiae was 1350 bp long and was 67% identical 
to the homologous gene in B. bacilliformis.  The B. clarridgeiae gene encoded a 450-aa 
polypeptide, and both the B. clarridgeiae and B. bacilliformis MotC proteins had no predicted 
transmembrane region and no predicted signal peptide.  Therefore MotC is most likely 
cytoplasmic.  The MotC proteins of B. clarridgeiae, B. bacilliformis, A. tumefaciens, B. 
melitensis, B.ovis, O. anthropi and S. meliloti were not well conserved and shared only 59 
identical amino acids, while B. melitensis, B. ovis and O. anthropi MotC proteins were 74.5% 
identical to each other.  Three signal sequence prediction programs indicated that the MotC 
proteins from Bartonella, and Brucella ovis did not have a signal sequence while S. meliloti, A. 
tumefaciens, Brucella melitensis and O. anthropi MotC proteins included a signal sequence. 
 The sequence of a 717-bp fragment of a gene downstream of motC was determined, and 
BLAST results indicated homology to a putative flagellar motor protein gene (motD) of B. 
bacilliformis.  No function or location has been attributed to MotD in B. bacilliformis.  The MotD 
in S. meliloti has been identified as homologous to FliK, the hook-length protein.  However, the 
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B. bacilliformis (and likely B. clarridgeiae) MotD has only a 53-aa similarity at the carboxy-
terminus to the MotD from S. meliloti.  
 
Site-directed mutations of B. clarridgeiae.  To construct a strain of B. clarridgeiae with no 
flagellum but with the other flagellar structures intact, a site-directed mutation in the flaA gene 
was generated.  Plasmid pPCRscript was used for this purpose because it replicates in E. coli but 
not in Bartonella.  The plasmid construct containing a 1025-bp region of the flaA gene was 
electroporated into B. clarridgeiae.  Thirty-two kanamycin-resistant colonies were tested for 
motility in semi-soft agar.  Six appeared to be deficient in motility.  Insertion of the suicide 
plasmid DNA into flaA was confirmed in two strains by PCR and sequencing. 
 
 
Figure 4.  Migration of B. clarridgeiae in motility agar.  Left upper and lower quadrants: flaA 
mutant.  Right upper and lower quadrants: wild-type B. clarridgeiae.     
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The non-motile mutants previously determined to contain transposons in motB and motC 
became non-viable after freezing.  In order to make a new mutant with a flagellum that did not 
turn, we decided to interrupt both the motB and motC genes.  A suicide plasmid containing a 
460-bp region encompassing the 3‟ end of motB and the 5‟ end of motC was constructed and 
electroporated into B. clarridgeiae. A total of 74 kanamycin-resistant, non-motile mutants were 
recovered, and interruption of motBC was confirmed in 4 strains by PCR and sequencing.  One 
flaA mutant, one motBC mutant and the B. clarridgeiae type strain were re-tested for motility 
and used in subsequent studies.  The photo of the flaA mutant in motility agar is shown in Figure 
4.  Like the flaA mutant, the motBC mutant also showed no expansion from the initial 
inoculation site (photo not shown).  The presence or absence of flagella was confirmed by 
transmission electron microscopy of B. clarridgeiae wild-type, flaA mutant and motBC mutant 
(Figure 5). 
 
Invasion of HMECs by B. clarridgeiae.  HMECs inoculated with B. clarridgeiae wild-type, the 
flaA mutant or motBC mutant were examined by transmission electron microscopy after 5 days.  
All three strains were able to enter HMECs.  Finger-like projections (filipodia) were seen 
surrounding individual bacteria in micrographs of all three strains (Figure 6,7,8).  No groups of 
bacteria were seen being engulfed, but several intact bacteria were seen together inside vacuoles.   
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Figure 5.  Transmission electron microscopy of B. clarridgeiae.  A) B. clarridgeiae wild-type, B) 
B. clarridgeiae flaA mutant, and C) B. clarridgeiae motBC mutant.  Flagella are indicated by 
arrows. 
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Figure 6.  Transmission electron microscopy of HMECs 5 days after inoculation with B. 
clarridgeiae wild-type.  A) Filipodium extending from HMEC, B) B. clarridgeiae inside HMEC 
vacuole. 
 
                           
Figure 7.  Transmission electron microscopy of HMECs 5 days after inoculation with B. 
clarridgeiae flaA mutant.   A) Filipodium extending from HMEC, surrounding bacterium, B) 
intact B. clarridgeiae flaA mutant inside HMEC. 
A B 
B A 
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Figure 8.  Transmission electron microscopy of HMECs 5 days after inoculation with B. 
clarridgeiae motBC mutant.   A) Many Filipodia extending from HMEC or surrounding 
bacterium; distinct Lamellipodia, Protrusion;  B) B. clarridgeiae motBC cell at HMEC 
membrane.  C) Distinct lamellipodia and D).a protrusion that resembles a pedestal. 
The HMECs were also examined by phase contrast microscopy every 12 hours after the 
bacteria were added to the culture.  At 24 hours post infection, the mock infected cells showed 
A 
C 
D 
B 
F 
 
P 
L 
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some signs of migration with long protrusions extending from the cell body (Figure 9A).  In 
Figure 9B, bacteria were seen in a mass on the surface of the HMEC. 
      
Figure 9.  Phase contrast microscopy after 24 hours.  A) uninfected HMECs, and B) HMECs 
infected with B. clarridgeiae wild-type.  Bacteria seen in mass attached to cell (arrow). 
The flaA mutant was also attached to cells as a group (Figure 10, A).  The motBC mutant 
attached to cells, but in this case, the bacteria were not in a large mass but covering the length of 
a membranous extension of the cell (Figure 10, B).  
          
Figure 10.  Phase contrast microscopy after 24 hours.  A) HMECs infected with B. clarridgeiae 
flaA mutant, and B) HMECs infected with motBC mutant.  In 10A, only few bacteria can be seen 
near or on left cell while a mass of bacteria can be seen at the surface of the right-hand cell 
(arrow).  In 10B, bacteria are attached to a long extension of the cell (arrow). 
A 
B A 
B 
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After 96 hours in culture without bacteria, the HMECs still appeared healthy (Figure 
11A). Many of the HMECs in culture with B. clarridgeiae wild-type were covered in clumps of 
bacteria, and some dark intercellular objects were seen surrounding the nucleus (Figure 11B, 
arrow). 
     
                 
Figure 11.  Phase contrast microscopy after 96 hours.  A) uninfected HMECs, and B) HMECs 
infected with B. clarridgeiae wild-type.  Bacteria can be seen intracellularly surrounding nucleus 
(arrow).  After 96 hours, the flaA mutant was attached to some cells and many dark perinuclear 
spots were evident (C). Some cells were covered in motBC mutant bacteria (D). 
D C 
A B 
 46 
 
No overall difference could be seen between the strains.  In all infected cultures, at all 
time points, some cells were seen with few if any attached bacteria and no intracellular 
organisms, while other cells had attached and intracellular organisms. 
In previous studies, endothelial cells infected with B. henselae have been shown 
engulfing the bacteria en masse in a structure called an invasome (Dehio et al.,1997).  No 
invasome structure was noted in our TEM or phase contrast micrographs of HMECs infected 
with B. clarridgeiae, so we used confocal microscopy to attempt to view an invasome of B. 
clarridgeiae if present.  In Dehio et al‟s article, the actin filaments were visualized forming the 
invasome structure (Dehio et al.,1997)  
In our study, HMECs inoculated and cultured with B. clarridgeiae were treated with F-actin 
phalloidin and propidium iodide to stain actin filaments green and bacteria and nuclear DNA red 
(Figure 12). 
A.         B.   
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C.         D.    
Figure 12.  Confocal transmission electron microscopy of HMECs stained with F-actin 
phalloidin and propidium iodide.  F-actin appears green, and bacteria and nuclear DNA appear 
red.  A) uninfected HMECs, B) HMEC infected with B. clarridgeiae wild-type, C) HMEC 
infected with flaA mutant, D) HMEC infected with motBC mutant.   Perinuclear bacteria (red) in 
C indicated with arrow.  
Bacteria were clearly visible surrounding the nucleus in the flaA mutant cells, and the wild-
type and motBC mutant were also seen in perinuclear locations (photos not shown).  Some 
parallel actin fibers could be seen in the wild-type and motBC mutant-infected cells, but no 
invasome structure was present in any cells.  The parallel actin fibers did not resemble the 
bundles of stress fibers seen in endothelial cells infected with B. bacilliformis (Verma et 
al.,2001).  
The transmission electron microscopy, phase contrast microscopy and confocal 
fluorescence microscopy showed that all three strains of B. clarridgeiae were able to enter 
HMECs, and no invasomes or stress fiber bundles were seen.  We interpret these results to mean 
that B. clarridgeiae, B. henselae and B. bacilliformis have different means to enter and/or cause 
different effects on HMECs once inside the endothelial cell.  Qualitatively, the motBC mutant-
infected HMECs appeared to have more bacteria intracellularly than the wild-type or flaA 
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mutant-infected cells (see 96 hour photos, Figure 11).  Some cells in each co-culture appeared to 
be uninfected for reasons unknown, and it was difficult to ascertain the ratio of infected and 
uninfected HMECs.  Therefore, to gain a more quantitative perspective, we used the gentamicin 
protection assay. 
 
Gentamicin protection assay.  We determined that 100% of B. clarridgeiae are killed by 
gentamicin at 250μg/ml (data not shown).  We used gentamicin to kill extracellular bacteria in 
HMEC-Bartonella co-cultures and lysed the HMECs to determine the number of intracellular 
bacteria.  The number of bacteria attached to the HMEC surface was also determined by lysing 
HMECs without gentamicin treatment.  Results shown in Figure 13 indicate that the intracellular 
percentage of the motBC mutant inocula was higher than the other strains at all time points.  
After 5 days, 72% of the motBC inoculum was either attached to (50%) or had entered (22%) the 
endothelial cells.  While the flaA mutant did not attach as well as the other two strains, it 
exhibited the highest percentage of cell-associated bacteria that had entered the cell at 5 days 
(37% compared to 19% wild-type and 30% motBC).  These observations suggest that the lack of 
flagella influences attachment more so than invasion.  When the flagellum was present but 
paralyzed (motBC), there was no decrease in the attachment and invasion ability of the bacteria 
at 3 and 5 days after inoculation.  In fact, attachment and invasion were enhanced in the motBC 
mutant compared to wild-type. 
 
Proliferation assay.  Some Bartonella species are  known for their mitogenicity (Dehio,2005).  
B. bacilliformis, B. henselae and B. quintana have all been shown to cause vasoproliferative 
diseases.  To investigate B. clarridgeiae‟s mitogenicity potential, we co-cultured HMECs with B. 
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clarridgeiae wild-type, the flaA mutant or the motBC mutant strain for 2 or 4 days.  We then 
treated the cultures with MTT, (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), 
a dye that is reduced to formazan in the mitochondria of living cells giving off a purple color 
when solubilized. 
 
  
Figure 13.  Gentamicin protection assay.  HMECS were inoculated with B. clarridgeiae at a ratio 
of 30 bacteria per cell.  After 1, 3 and 5 days, the cells were washed to remove unattached 
bacteria and lysed without or after gentamicin treatment.  WT, wild-type extracellular and 
intracellular; flaA, flaA mutant extracellular and intracellular; motBC, motBC extracellular and 
intracellular; WT-int, wild-type intracellular only; flaA-int, flaA mutant intracellular only; 
motBC-int, motBC mutant intracellular only. 
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Figure 14.  Proliferation assay.  HMECs were inoculated with 10, 30 or 100 bacteria per cell.   
After 2 or 4 days, MTT was added to each well.  After 4 hours, a solubilizer was added and 
incubated overnight.  Increased incorporation of MTT is indicative of increased cell number. 
WT= wild-type B. clarridgeiae, f= flaA mutant, m= motBC mutant.  The values are expressed as 
the percentage of the negative control values. 
At 2 days post infection, all infected HMECs had a lower proliferative index than the 
negative control.  However, after 4 days, the WT10, f10, m10 and m30 had significantly 
increased proliferative values compared to the negative control, p<0.05.  Furthermore, all 
reactions showed significantly less proliferation than the f10 infected cells after 4 days, p<0.02. 
Taken together, the gentamicin protection assay and MTT assay results suggest that the 
flaA mutant attaches significantly less well than the motBC mutant or wild-type B. clarridgeiae 
but has a greater proliferative effect. 
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The apparent proliferative effect of the flaA mutant may be due to increased cytotoxicity 
of HMECs by the wild-type or the motBC mutant. To determine if the strains were cytotoxic to 
HMECs, we performed lactase dehydrogenase cytotoxicity assays on the HMEC co-cultures. 
 
Figure 15.  Cytotoxicity assay.  HMECs inoculated with B. clarridgeiae or uninfected.  After 2, 3 
or 4 days, the HMECs were assayed for lactose dehydrogenase release indicating cell damage or 
lysis.  Values are expressed as percent of control.  Control = uninfected HMECs.  WT= wild-
type B. clarridgeiae , f= flaA mutant, m=motBC mutant.  10, 30 and 100 are bacteria per 
endothelial cell ratio.  Students t-test was used to determine significant differences. 
After 2 days, WT10, WT30, f10, f30, and m10 had lower LDH values than the negative 
control (p<0.02).  M30 was 103% of the control value (p=0.04).  At 3 days post inoculation, the 
WT30 had a higher LDH than the control (p=0.01).  After 4 days, WT30, WT100, f100, and 
m100 displayed more cytotoxicity than the uninfected control (p<0.05), but they were not 
significantly different from one another. 
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Lower concentrations of bacteria did not have a cytotoxic effect on the HMECs at the 2-
day time point and may actually have protected cells from damage.  Higher bacteria to cell ratios 
resulted in cell death.  Over the 4-day time span, an increase in cell cytotoxicity in cultures 
containing the lower concentrations of bacteria became apparent.  This may have been due to 
bacterial growth in the culture, resulting in a higher bacteria to cell ratio. 
Overall, these experiments suggest that wild-type B. clarridgeiae is able to enter HMECs 
and cause significant proliferation if the bacteria to cell ratio is less than 1:100.  B. clarridgeiae 
without flagella (flaA) induces more of a proliferative effect, and the paralyzed but intact 
flagellar mutant (motBC) appears to be able to enter the HMECs in greater number than the wild-
type or the mutant that lacks flagella. 
 
Discussion 
Bartonella species are emerging zoonotic pathogens.  Bartonella henselae is the major 
causative agent of Cat Scratch disease in humans (Scott et al.,1996).  B. clarridgeiae has been 
found with B. henselae in cats and cat fleas in many regions of the world (Rolain et al.,2003; 
Kelly et al.,2004; Li et al.,2007), and has been associated with endocarditis and hepatic lesions 
in dogs (Chomel et al.,2001; Gillespie et al.,2003).  Although B. clarridgeiae has not been 
isolated from humans, molecular and serologic results have implicated B. clarridgeiae in Cat 
Scratch Disease and a chest wall abcess (Kordick et al.,1997; Margileth and Baehren,1998).  In 
immunocompetent humans, infection with Bartonellae typically results in a self-limiting benign 
erythrocyte parasitism from a primary niche thought to be the vascular endothelium.  B. 
bacilliformis is the exception and causes major hemolysis.  In immunocompromised individuals, 
and those individuals who survive the initial phase of B. bacilliformis infection, B. bacilliformis, 
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B. henselae and B. quintana can cause angiogenesis manifesting as vasoproliferative lesions such 
as bacillary angiomatosis, peliosis or verruga peruana.  Until now, it was not known whether B. 
clarridgeiae had the capacity to invade human cells and/or cause proliferation, both prerequisites 
for angiogenesis.  Our experiments sought to determine whether 1) B. clarridgeiae could invade 
HMECs, and 2) if yes, to what extent flagella and motility were involved in the B. clarridgeiae 
invasion process.  
Bacillary angiomatosis caused by Bartonellae is similar to angiogenesis in embryonic 
development and in the spouting of vessels feeding cancerous tumors.  These conditions are all 
complicated processes of morphogenesis resulting in the formation of new vasculature from pre-
existing vessels (Carmeliet,2003).  The first step in Bartonellae-induced angiogenesis is the 
colonization of endothelial cells.  B. bacilliformis has been  shown to subvert Rho GTPases to 
rearrange the endothelial cell cytoskeleton and induce bacterial uptake in vitro (Verma et 
al.,2000; Verma et al.,2001; Verma and Ihler,2002).   B. henselae also induces major 
cytoskeletal rearrangement to form the invasome that engulfs a mass of bacteria (Dehio et 
al.,1997).  In our experiments, B. clarridgeiae entered HMECs as single bacteria and no 
invasome structure was seen.  Additionally, stress fiber bundles shown to be present during B. 
bacilliformis invasion were not visible when HMECs infected with B. clarridgeiae were viewed 
under confocal microscopy.  The uptake of B. clarridgeiae is most likely actin-dependent, and 
evidence of that was seen in the TEM photographs of filipodia reaching out towards and 
surrounding individual B. clarridgeiae cells (Figures 6-8).  However, the massive 
rearrangements of the cytoskeleton seen in cells infected with B. henselae and B. bacilliformis 
were not evident in B. clarridgeiae-infected cells. 
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What could account for the different invasion processes of B. clarridgeiae, B. henselae 
and B. bacilliformis?  In B. henselae, the VirB type 4 secretion system causes massive 
cytoskeletal rearrangement and formation of the invasome most likely through the translocation 
of one or more Bep proteins (Dehio,2004; Schmid et al.,2004).  B. clarridgeiae has homologues 
of genes virB2-virB11 (D. Kohlhorst, dissertation, Georgia State University), but it is unknown 
whether there is a VirD4, the type 4 secretion coupling protein essential for substrate 
translocation.  Given what is known about the arrangement of virB genes in B. clarridgeiae, B. 
henselae, B. tribocorum and B. quintana, it is likely that B. clarridgeiae has the same general 
virB/virD4/bep pathogenicity island arrangement as the other 3 Bartonella species in which the 
Bep protein genes are contiguous with the VirB protein genes (Schroder and Dehio,2005)). 
Evidence that the Bep proteins translocated by B. henselae are involved in the formation 
of the invasome stems from a report that a deletion of all of the bep genes bepA-bepG results in 
the same phenotype as a ΔvirD4 or ΔvirB4 mutant; there is (a) no massive rearrangements of the 
actin cytoskeleton, (b) no inhibition of apoptosis, and (c) no activation of NF-κB 
proinflammatory response (Schulein et al.,2005).  If the VirB T4SS is functional in B. 
clarridgeiae, and if the VirB system secretes Bep proteins, then perhaps 1) the Bep proteins in B. 
clarridgeiae do not function in exactly the same manner as the Bep proteins in B. henselae, e.g., 
massive cytoskeletal rearrangement, or 2) the B. clarridgeiae Bep protein that is involved in 
cytoskeletal rearrangements causes only small cytoskeletal changes, or 3) the Bep protein that is 
involved in cytoskeletal rearrangements in B. henselae and B. clarridgeiae (and others) is only 
indirectly involved and the other protein(s) necessary for the massive rearrangement is not 
functional or present in B. clarridgeiae; or 4) the full complement of Bep protein genes is 
incomplete in B. clarridgeiae.  The last option may be the case for B. quintana which appears to 
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have only 4 of the 8 Bep protein genes.  Since B. quintana does not induce invasome formation, 
the Bep protein responsible for the massive cytoskeletal rearrangement may be missing.  
Sequencing of the region downstream of virB11 in B. clarridgeiae to determine the presence of 
the bep genes, and testing a bep deletion mutant in HMEC culture would be informative. 
B. bacilliformis does not possess a VirB T4SS or bep genes but induces its own 
phagocytosis through cytoskeletal rearrangement involving activation of small GTPases in the 
host cell (Rho, Rac and Cdc42) by an undetermined mechanism (Verma and Ihler,2002). 
Cytochalasin D which inhibits actin polymerization, reduced the intracellular numbers of B. 
bacilliformis by only 75% indicating that additional factors from B. bacilliformis are responsible 
for part (25%) of the endocytic process (Hill et al.,1992).  The small GTPases Rac and Cdc42 are 
known to be involved in formation of lamellipodia and filopodia, respectively, which engulf B. 
bacilliformis (Verma and Ihler,2002).  Inactivation of endothelial Rac, Rho and Cdc42 GTPases 
reduced the entry of B. bacilliformis by 80-90% (Verma and Ihler,2002).  However, the stress 
fibers caused by activation of Rho are not involved in the internalization process and are 
considered an effect of internalization (Verma et al.,2001).  The mechanism used by B. 
bacilliformis to gain entry into endothelial cells may be very similar to that used by B. 
clarridgeiae.  Therefore, the lack of stress fibers when B. clarridgeiae invade may be a result of 
different bacterial factors released after the bacteria enter the endothelial cell.   
Other bacteria have been found to influence the actin cytoskeleton for their own 
micropinocytosis.  Shigella protein IpaC is secreted by the Mxi-Spa type 3 secretion system and 
leads to entry of Shigella into HeLa cells via lamellipodia and filipodial extensions (Tran Van 
Nhieu et al.,1999).  Actin rearrangement at the site of bacterial attachment is induced by IpaC 
and involves Rac and Cdc42 (Tran Van Nhieu et al.,1999).  Rho, Rac and Cdc42 are required for 
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internalization of B. abortus, and a BvrR/BvrS mutant was reported to be unable to recruit these 
GTPases (Guzman-Verri et al.,2001).  BvrR/BvrS is a two-component regulatory system highly 
homologous to systems in other alpha-proteobacteria, including the ChvI/ChvG of A. 
tumefaciens and BatR/BatS in Bartonella.  We discovered batR/batS genes in B. clarridgeiae 
(data not shown), and they have been sequenced from B. bacilliformis, B. tribocorum, B. 
quintana, B. taylorii, and B. henselae.  The role of BatR/BatS in Bartonella is unknown; 
however, the Brucella abortus BvrR/BvrS system regulates expression of outer membrane 
proteins (Lamontagne et al.,2007).  No outer membrane proteins have been identified in B. 
clarridgeiae yet, but variable outer membrane proteins (Vomps) of B. quintana have been shown 
to be involved in induction of VEGF from macrophages and epithelial cells (Schulte et al.,2006).  
Other outer membrane proteins described as virulence factors in Bartonellae include the adhesin 
BadA, an outer membrane protein found in B. bacilliformis, B. henselae, and B. quintana, and  
GroEL, a chaperonin protein localized to the outer membrane of B. bacilliformis and B. henselae 
(Minnick et al.,2003; Boonjakuakul et al.,2007).  We discuss GroEL in more detail in Chapter II. 
 B. bacilliformis and B. clarridgeiae are 2 of 5 Bartonella species that have a flagellar 
system.  Flagella are assembled using a flagellar-specific type III secretion system (T3SS) that is 
very similar to the T3SS called the injectisome found in many other bacteria.  No trace of either 
the flagellar or injectisome system is present in B. henselae or B. quintana.  Instead, B. henselae 
and B. quintana have two T4SS, VirB and Trw.  The ancestral species B. bacilliformis, B. 
clarridgeiae, and the ruminant-specific sub-lineage B. bovis, B. capreoli, B. chomelii and B. 
schoenbuchensis have flagella and no Trw T4SS (Schroder and Dehio,2005; Dehio,2008).   It 
has been postulated that Bartonellae have replaced the flagellar system with the Trw T4SS 
during adaptive evolution (Saenz et al.,2007). Evidence points to flagella as more than just a 
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means of propulsion in B. bacilliformis, however.  Anti-flagellin antibodies inhibited B. 
bacilliformis from entering erythrocytes by 99% and whole-cell antibodies to B. bacilliformis 
reduced the bacteria from entering HUVECs by 50% (Hill et al.,1992; Scherer et al.,1993).  Our 
results using a flaA mutant void of flagella indicated that flagella are important for attachment to 
HMECs, but that motility was much less important, as the motBC mutant that had intact flagella 
but was non-motile was able to attach and invade at even higher numbers than the wild-type 
strain at days 3 and 5 post-inoculation (Figure 13).  The B. clarridgeiae flaA mutant was able to 
enter the HMECs once it attached to the cell.  This finding suggests that the external flagellar 
filament is not necessary for invasion per se, although we have not ruled out that it participates in 
the invasion process at the attachment stage.  Another possible explanation is that the bacteria 
that entered the HMECs were revertants or had a second site compensatory mutation that aided 
the invasion process. 
Wild-type B. clarridgeiae, the flaA mutant and the motBC mutant were mitogenic at low 
doses after 4 days of culture with HMECs, but proliferation was negligible at an MOI of 100 
compared to uninfected HMECs (Figure 14).  The latter effects were due, at least in part, to 
cytotoxicity of the 3 strains at higher doses after 4 days‟ incubation with the host cells (Figure 
15).  Proliferation was significantly increased in the flaA mutant cultures at the lowest dose 
(MOI=10) at day 4 compared to that of the wild-type or motBC mutant cultures.  These results 
are similar to those seen in with a B. henselae ΔvirB4 mutant except that the ΔvirB4 mutant 
cultures showed enhanced proliferation even at the highest MOI (Schmid et al.,2004).  Schmid et 
al. (2004) reasoned that VirB is involved in a cytostatic effect that interferes with proliferation 
and is cytotoxic at high concentrations.  When VirB is deleted, the cytostatic and cytotoxic 
effects are not seen and proliferation, caused by an elusive mitogen that is not a substrate of 
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VirB, increases significantly (Schmid et al.,2004).  The cytotoxicity seen with high 
concentrations of B. clarridgeiae may also be VirB-dependent.    
A link between the flagellar system and the VirB T4SS has not been postulated 
previously.  However, negative crosstalk between the flagellar T3SS and the non-flagellar T3SS 
has been documented in Pseudomonas aeruginosa (Soscia et al.,2007).  Secretion of effector 
proteins from the T3SS was enhanced in the non-flagellated mutant (Soscia et al.,2007).  Perhaps 
the enhanced proliferation of HMECs by the B. clarridgeiae flaA mutant was not due to a 
decrease in cytostasis but rather an increase in the production and/or secretion of a mitogenic 
factor.  At low concentrations, the mitogen expressed by B. clarridgeiae wild-type and the 
motBC mutant may overcome a cytostatic effect of a possible VirB-dependent substance, 
resulting in the proliferation that is seen at day 4 post infection (Figure 14).  The flaA mutant, 
however, may express a higher concentration of the mitogen while the concentration of the 
cytostatic substance remains the same.  At high concentrations of all three strains, the cytostatic 
substance is presumed to have a greater effect than the mitogen.  GroEL is found in B. 
bacilliformis culture supernatants and has been implicated as a mitogenic factor for HUVECs 
(Minnick et al.,2003; Callison et al.,2005; Smitherman and Minnick,2005).  The secretion 
mechanism for GroEL in B. bacilliformis is unknown, but B. bacilliformis does not have a VirB 
system.  It is tempting to speculate that B. clarridgeiae might secrete GroEL and that this 
substance may be mitogenic for HMECs.  If so, this raises the possibility that the flaA mutant 
secretes more GroEL than the wild-type strain  
Although the percentages of the motBC mutant and wild-type B. clarridgeiae associated 
with endothelial cells during the invasion assay (Figure 13) were similar, the motBC mutant was 
able to enter the cells in higher numbers than the wild-type (22% vs. 11% of the inoculum was 
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intracellular, respectively).  These results were comparable to those reported for a ΔvirB4 mutant 
of B. henselae.  Schmid et al. (2004) proposed that the increased numbers of intracellular ΔvirB4 
bacteria relative to the wild-type may have been due to increased endocytosis (since the 
invasome was not formed) and that endocytosis occurs at a much faster rate than the invasome-
mediated invasion.  Therefore, according to this model, wild-type B. henselae were slower to 
appear intracellularly because of their dependence on invasome formation.  This appears not to 
be the explanation for wild-type B. clarridgeiae, as no invasomes were seen by transmission or 
confocal microscopy. 
Why would a non-motile mutant invade better than wild-type?  The motBC mutant has a 
complete flagellar filament, and experiments with our flaA mutant suggested that the filament 
aids in attachment but is perhaps only minimally involved, if at all, in invasion.  Is the energy 
normally used for rotation used for another function if the motor is not complete?  Komoriya et 
al. (1999) reported the isolation of a ΔmotAB mutant of Salmonella typhimurium that secreted 
more flagellin and less virulence protein than the wild-type strain.  They reasoned that kinetics 
for export systems, either ATP or proton motive force, may have been disrupted by the motAB 
mutation.  Antibodies made against B. bacilliformis  flagellar filaments inhibited the bacteria 
from iinvading erythrocytes (Scherer et al.,1993). Similarly, whole cell antibody raised against a 
crude cell wall preparation from B. bacilliformis  blocked the organism‟s entry into HUVECs 
(Hill et al.,1992). 
 If B. clarridgeiae motBC mutant, an increased secretion of flagellin protein would be 
predicted to block attachment of B. clarridgeiae if the similarities with B. bacilliformis hold true, 
so that may not be what was occurring in our experiments.  Perhaps a mutation in motB and 
motC rather than motA leads to decreased flagellin secretion and increased secretion of virulence 
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factors through an as yet undetermined mechanism.  Rajagopala et al recently determined that 
there are over 100 protein-protein interactions involved in a complex chemotaxis and motility 
network, so unraveling the link between the flagellar system in B. clarridgeiae and B. 
bacilliformis and invasion may be very complex (Rajagopala et al.,2007).  
In the present study, wild-type B. clarridgeiae, a mutant with no flagella (flaA) and a 
mutant with paralyzed flagella (motBC) were analyzed for their ability to enter endothelial cells 
and their effects on the endothelial cells in co-culture.  All three strains were able to enter human 
microvascular endothelial cells, and all appeared to enter as single bacterial cells rather than in 
groups.  The motBC mutant entered the HMECs in greater total numbers than the other two 
strains; however, the flaA mutant caused the most proliferation of the HMECs.  All three strains 
caused cytotoxicity when the MOI was high.   
In order to determine if secretion of a mitogen or other factor was increased or decreased 
in the flaA mutant or motBC mutant culture compared to the wild-type infected HMECs or 
uninfected HMECs, we next examine culture supernatants for differential protein secretion 
(Chapter II). 
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CHAPTER II 
The Secretome of B. clarridgeiae and Human Microvascular Endothelial Cells 
 in Co-Culture 
Introduction 
The ability of B. henselae, B. bacilliformis and B. quintana to cause the development of 
new blood vessels from existing vessels in humans, a process called angiogenesis, is a unique 
feature of these bacteria.  During angiogenesis, activated endothelial cells degrade the 
extracellular matrix, proliferate and migrate to form new capillaries (Risau,1997).  While the 
exact mechanism is unknown, proliferation of endothelial cells by B. henselae is independent of 
the type 4 secretion system (T4SS) VirB.  However, the VirB system is responsible for several 
changes in the endothelial cells necessary for angiogenesis.  The VirB system translocates 
proteins into the endothelial cells resulting in cytoskeletal rearrangements, the induction of a pro-
inflammatory response through NFκB, and inhibition of apoptosis (Schmid et al.,2004). The 
cytoskeletal rearrangements enable the engulfment of large aggregates of B. henselae (Schmid et 
al.,2004).  B. henselae may directly stimulate endothelial cell proliferation and also trigger a 
paracrine proangiogenic stimulus through NFκB activation (Dehio,2003).  NFκB induces IL-8 
secretion and results in the chemoattraction of macrophages which then secrete vascular 
endothelial growth factor (Dehio,2003).  The anti-apoptotic effect of B. henselae infection is 
mediated by the VirB-translocated protein BepA (Schmid et al.,2006). 
 Kirby and Nekorchuk reported that the increase in endothelial cell numbers in culture 
with B. henselae was not due to proliferation, per se, but to the inhibition of apoptosis (Kirby and 
Nekorchuk,2002).  An anti-apoptotic factor is released by B. henselae in culture media in the 
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presence or absence of endothelial cells (Kirby and Nekorchuk,2002).  B. bacilliformis, on the 
other hand, releases a proteinaceous factor(s) in culture supernatants that is mitogenic, not anti-
apoptotic (Minnick et al.,2003).  At least one of the B. bacilliformis factors was reported to be 
the chaperonin GroEL (Minnick et al.,2003). 
In the preceding experiments, we have shown that B. clarridgeiae iss able to invade 
human endothelial cells in vitro and cause proliferation.  Additional information is needed to 
determine if B. clarridgeiae has effects on endothelial cells similar to those of the proangiogenic 
Bartonellae and whether the effects are due to bacterial secreted proteins such as GroEL.  The 
mechanism by which GroEL is secreted is unknown, but B. bacilliformis does not have a VirB or 
Trw secretion system.  Both B. clarridgeiae and B. bacilliformis have flagella, and the Trw 
secretion system has been postulated to be a replacement for the flagellar system during radial 
speciation of Bartonella (Dehio,2008).  Secretion of virulence factors by the flagellar export 
system has been demonstrated in C. jejuni and Y. enterocolitica (Young et al.,1999; Konkel et 
al.,2004).  We have shown that B. clarridgeiae is motile but does not form the large diameter 
rings that A. tumefaciens does in motility agar (Merritt et al.,2007).  Perhaps the primary 
function of flagella and the flagellar type three secretion system (T3SS) in B. bacilliformis and B. 
clarridgeiae is protein secretion not motility.     
In the following sections, we report the construction of a non-motile flaA mutant strain of 
B. clarridgeiae lacking the flagellar filament and a motBC mutant strain with paralyzed flagella. 
We examined the proteins released into the media when wild-type and mutant B. clarridgeiae 
and HMECs were co-cultured in order to characterize the secreted bacterial proteins and the 
proteins secreted by the HMECs in response to B. clarridgeiae.   
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Materials and Methods 
 
Bacteria.  B. clarridgeiae type strain ATCC 51734 was grown for 5 days on heart infusion agar 
with 5% rabbit blood (HIA-RB) at 37°C and 5% CO2.  Two non-motile strains of B. clarridgeiae 
were created by interrupting the flaA flagellin gene and the flagellar motor genes motBC, as 
previously described (Chapter I).   B. clarridgeiae mutants were grown on HIA supplemented 
with Kanamycin 50μg/ml. 
 
Protein collected from HMEC and B. clarridgeiae co-culture.  HMECs at 1x10
5
/ml were 
seeded into 150-cm
2
 culture flasks with MCDB-131 media containing 10% fetal calf serum and 
2mM L-glutamine and allowed to grow to confluency at 37°C.  The medium was removed, and 
the cells were washed with media without serum, followed by a 30-minute incubation in media 
without serum.  This procedure was followed to remove as much serum as possible from the 
cells so that serum proteins would not mask bacterial and HMEC-secreted proteins when 
electrophoresed.  One set of 10 flasks served as the uninfected control.  One set was inoculated 
with B. clarridgeiae wild-type ATCC 51734, one with the flaA mutant and one set with the 
motBC mutant strain.  Bacteria were added to 10 flasks at a MOI of 100 in fresh media with no 
serum but containing L-glutamine and fungizone and incubated for 2-5 days at 37 C with 5% 
CO2.  The medium was collected and proteinase inhibitors were added.  The medium was then 
filter-sterilized through 0.2µM filter units and lyophilized in 10-ml aliquots. 
 
2-D gel electrophoresis.  Sets of like samples (e.g. media from uninfected controls) were 
dissolved in minimal amounts of SDS Boiling Buffer (5% SDS, 10% glycerol and 60 mM Tris, 
pH 6.8), combined and lyophilized a second time.  The lyophilized material was redissolved in 
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ultrapure water and dialyzed for 2 days against 5 mM tris, pH 6.8 using 6-8,000 molecular 
weight cutoff membranes at 4°C.  After dialysis, the samples were lyophilized again, redissolved 
in 1200 μl of 1:4 diluted SDS Boiling Buffer :water and heated in a boiling water bath for 3 
minutes.  The protein concentrations of the samples were determined using the BCA Assay  
(Smith et al.,1985).  The samples were then diluted to 1 mg/ml in 1:1 diluted SDS Boiling Buffer 
(5% SDS, 5% BME, 10% glycerol and 60 mM Tris, pH 6.8) Urea Sample Buffer (9.5 M urea, 
2% w/v IGEPAL CA-630 (a non-ionic detergent, or Nonidet P-40), 5% beta-mercaptoethanol 
(BME), and 2% ampholines consisting of 1.6% pH 5-7 and 0.4% pH 3.5-10 (Amersham 
Biosciences, Piscataway, NJ), centrifuged at 2500xg for 10 seconds, and the supernatants were 
loaded on polyacrylamide tube gels. 
For the first dimension of the 2-dimensional polyacrylamide electrophoresis, 100µg of 
total protein was separated by isoelectric focusing in glass tubes of inner diameter 3.5 mm, using 
2% pH 3.5-10 (GE Healthcare, Piscataway, NJ) for 20,000 volt-hrs. An IEF internal standard, 
50ng Tropomyosin, was added to each sample prior to loading.  The tube gels were equilibrated 
after the first dimension run in SDS sample buffer (10% glycerol, 50 mM dithiothreitol, 2.3% 
SDS and 0.0625 M tris, pH 6.8) for 10min, then each tube gel was sealed to the top of a stacking 
gel that overlays a 10% acrylamide slab gel (1.0 mm thick). SDS slab gel electrophoresis was 
carried out for about 5 hrs at 25 mA/gel.  The following proteins (Sigma Chemical Co, St. Louis, 
MO) were added as molecular weight markers: myosin (220,000), phosphorylase A (94,000), 
catalase (60,000), actin (43,000) carbonic anhydrase (29,000) and lysozyme (14,000). The gels 
were stained with Coomassie brilliant blue R-250 overnight, destained in 50% methanol/10% 
acetic acid and dried between sheets of cellophane.  At least two gels were run with each sample.  
Spot density was determined by Progenesis SameSpots software (Non-Linear Dynamics, 
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Durham, NC).   Spot density values were normalized by determining a single spot density value 
as the percentage of total density in all spots analyzed in that sample. 
 
Mass spectrometry.   Protein spots excised from Coomassie Blue-stained 2D gels were 
subjected to in-gel digestion followed by micro-purification using a ZipPlate micro-SPE 
according to manufacturer‟s In-Gel Digestion Protocol (Millipore) with minor modifications.  
Briefly, gel spots were destained in buffer 1 (25 mM ammonium bicarbonate and 5% 
acetonitrile) for 30 min and then in buffer 2 (25 mM ammonium bicarbonate and 50% 
acetonitrile) foran additional 30 min and the steps were repeated until the blue color disappeared.  
After reducing with 10 mM DTT and alkylating with 55 mM iodoacetamide, the gel pieces were 
digested in a 15-µL reaction solution (25 mM ammonium bicarbonate) containing 0.1 – 0.2 µg of 
trypsin and the reaction was incubated overnight at 37ºC.  The solution containing the peptide 
digest obtained from extraction and micro-purification was dried in a vacuum centrifuge and 
resuspended in 1% formic acid and 2% acetonitrile for mass spectrometric analysis. Nano LC-
MS/MS analysis was performed in a Micromass Q-TOF Ultima mass spectrometer equipped 
with a nanospray ion source and coupled with an nanoAcquity ultraperformance liquid 
chromatography system (UPLC) (Waters, Milford, MA). The acquisition of data was performed 
on a MassLynx data system (version 4.0) using a data-dependent mode where three most intense 
precursors in a survey scan were isolated for collision-induced dissociation. Resulting MS/MS 
data were used to search for protein candidates by automated database searching against the 
NCBInr database using MASCOT Daemon software (Matrix Sciences).  An additional search 
was conducted against a database of proteins predicted from genome sequences of Bartonella 
species and closely related bacteria in the Order Rhizobiales.  
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Results 
Four sets of flasks with confluent monolayers of HMECS were inoculated with B. 
clarridgeiae wild-type, the flaA mutant, the motBC mutant or were grown without bacteria.  
After 5 days, the culture supernatants were recovered and the proteins were separated on 2-D 
gels.  Over 400 protein spots were detected in each gel. 
         
       
Figure 16.  2-D gel electrophoresis of proteins from culture media.  A) uninfected HMECs; B) 
HMECs infected with B. clarridgeiae wild-type; C) HMECS infected with flaA mutant; D) 
HMECs infected with motBC mutant. 
A B 
C D 
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 Spot densities were determined and the percentage of total protein that each spot 
represented was calculated.  To identify proteins that were common to all 4 gels, and therefore 
not secreted by HMECs because of bacterial infection or secreted by bacteria, 10 spots with the 
same approximate density in all 4 gels were cut out of the Coomassie stained gels and analyzed 
by mass spectrometry.  More than one identification was made for 4 of the spots.  This result 
could be due to 2 or more proteins having the same apparent molecular weight and pI, or the 
peptides identified were found in 2 or more proteins in the database.  
  
Table 3.  Identification of Proteins Found at Equivalent Densities in All HMEC Cultures 
Spot 
# of 
Potential 
Identities 
Protein Name
1
  Accession ID. 
2
 M.W. (kDa) pI Score 
3
 
Matched 
Peptides 
4
 
Sequence 
Coverage 
(%) 
71 1 Glutathione synthetase  GSHB_HUMAN 52352 5.67 403 9 21 
88 1 Plasminogen activator inhibitor 1 precursor  PAI1_HUMAN 45031 6.68 1146 51 64 
  2 Fumarate hydratase FUMH_HUMAN 54602 8.85 134 5 13 
  3 Alpha-enolase  ENOA_HUMAN 47139 7.01 133 3 11 
165 1 Transaldolase TALDO_HUMAN 37516  6.36 229 6 16 
227 1 Purine nucleoside phosphorylase  PNPH_HUMAN 32097 6.45 433 16 41 
243 1 Nicotinamide N-methyltransferase  NNMT_HUMAN 29555 5.56 148 7 27 
260 1 3,2-trans-enoyl-CoA isomerase D3D2_HUMAN  32795 8.80 360 9 29 
  2 Enoyl-CoA hydratase ECHM_HUMAN 31367 8.34 223 10 26 
307 1 Proteasome subunit beta type 2 PSB2_HUMAN  22822 6.51 330 9 38 
  2 Peroxiredoxin-1 PRDX1_HUMAN  22096 8.27 110 3 15 
317 1 Protein DJ-1 PARK7_HUMAN 19878 6.33 332 8 46 
  2 Peroxiredoxin-2 PRDX2_HUMAN 21878 5.66 227 8 32 
  3 Heme-binding protein 1 HEBP1_HUMAN 21084 5.71 163 6 39 
  4 Ras-related protein Rab-11A  RB11A_HUMAN 24378 6.12 119 3 15 
368 1 Hippocalcin-like protein 1 HPCL1_HUMAN 22299 5.21 132 5 24 
395 1 Elongation factor 1-gamma  EF1G_HUMAN 50087 6.25 422 8 15 
 
 Many of the proteins found in all of the culture supernatants are involved in normal 
homeostasis and metabolism.  Glutathione synthetase and peroxiredoxins are involved in 
protection from oxidative stress and regulation of cell proliferation.  Transaldolase is an enzyme 
in the pentose phosphate pathway, and purine nucleoside phosphorylase acts in the metabolism 
of purine.  Nicotinamide N-methlytransferase is an enzyme that recycles nicotinamide back to 
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NAD.  Fatty acid oxidation uses 3,2-trans-enoyl-CoA isomerase.  Hippocalcin-like protein 1 may 
inhibit apoptosis (Mercer et al.,2000; Korhonen et al.,2005).  Elongation factor 1-gamma is a 
subunit of the multimeric human Elongation factor responsible for transferring aminoacyl-tRNAs 
to the ribosome during translation of mRNA to polypeptides.   
 We next examined spots on each 2-D gel that were differentially secreted.  Sixty-seven 
spots were selected and subjected to trypsin digestion and LC-MS/MS spectrometry.  Peptide 
fingerprint analysis and comparison to the NCBI non-redundant database and Rhizobiales-
specific database revealed possible, plausible identifications for the majority of the proteins.  
MASCOT scores of more than 50 with 2 or more peptide matches are presented in Table 4. 
When compared with uninfected HMECs, the culture supernatant from the HMECs in co-
culture with wild-type B. clarridgeiae contained an increased amount of glycolytic proteins such 
as pyruvate kinase and malate dehydrogenase.  During glycolysis, pyruvate kinase acts on 
phosphoenolpyruvate to produce pyruvate and ATP (Mazurek et al.,2005).  Malate 
dehydrogenase is an enzyme necessary for carbohydrate catabolism that catalyzes the transition 
from malate to oxaloacetate in the Krebs cycle.  The enzyme thioredoxin reductase (TrxR) is part 
of the thioredoxin (Trx) redox system which is found in virtually all organisms (Arner and 
Holmgren,2000).  The Trx system has many functions including working with peroxiredoxins to 
reduce hydrogen peroxide, reducing ribonucleotides during DNA synthesis, regulating of 
transcription factors such as NFκB, and inhibiting of apoptosis (Arner and Holmgren,2000). 
Other regulatory proteins were found in the wild-type B. clarridgeiae supernatant.  
Protein-L-isoaspartate O-methyltransferase (PIMT), which repairs damaged proteins, also 
protects cells against apoptosis (Huebscher et al.,1999).  Heat shock proteins such as Hsp70 are 
found in most organisms and protect cells against stress including heat and can also act as 
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chaperones for other proteins.  F-actin capping protein regulates the actin cytoskeleton 
distribution in cells and is essential for motility (Wear et al.,2003). The proteasome activator 28α 
subunit plays a role in degradation of proteins by stimulating the activity of the proteasome 
(Tanahashi et al.,1997).  The proteasome degrades misfolded or damaged proteins that have been 
modified by ubiquitinylation and is involved in many, if not most, of the functions that take place 
in mammalian cells (Hilt and Wolf,2004).   
Table 4.  Identification of Proteins Found in Spots at Different Densities in the 4 Cultures 
Protein Source Peptides Score 
Bc WT 
vs. NC 
Bc flaA 
vs. NC 
Bc motBC 
vs. NC 
Pyruvate kinase M1/M2 Human 27 799 Upa Up Down 
Thioredoxin reductase Human 20 734 Up Up Down 
Malate dehydrogenase Human 3 122 Up Nc Up 
Protein-L-isoaspartate O-
methyltransferase Human 14 413 Upb Up Up 
HSP70 human 6 192 Up Up NC 
Proteasome activator 28-alpha 
subunit human 6 118 Up Up NC 
Aldoketo reductase family 1 human 6 179 Up Up Up 
Ubiquitin conjugating enzyme E2 human 3 73 NC Up NC 
Galectin 1 human 4 90 NC Up NC 
Tissue inhibitor of 
metalloproteinase 1 human 2 52 Up Up NC 
Triose phosphate isomerase human 7 161 Up Up NC 
Stathmin human 5 183 NC Up NC 
Proteasome subunit beta type 3 human 17 544 Down NC NC 
Vimentin human 11 503 NC Up Down 
Peroxiredoxin 1 human 6 222 NC Nc Up 
SH3 domain binding glutamic acid 
rich protein human 6 288 NC Nc Up 
Plasminogen activator inhibitor 1 human 31 951 NC Nc Up 
Dimethylarginine 
dimethylaminohydrolase human 11 379 NC Nc Down 
Lamin A/C human 9 363 NC Nc Down 
Insulin-like growth factor binding 
protein 7  human 3 127 NC Nc Down 
Acetyl-Coenzyme A 
acetyltransferase human 5 161 Up Up Down 
PPIC-type PPIase domain protein bacteria 4 266 NC NC Up 
GroEL bacteria 7 298 Up NF NF 
GroES bacteria 5 135 Up Up Up 
 NC, no change.  Up, increased. Down, decreased. NF, not found. 
a 
medium blue, 
 Up 2-5-fold. 
b
Dark blue
,
Up 5-40-fold. 
 
Tissue inhibitor of metalloproteinase-1 was also found in the B. clarridgeiae cell culture media. 
TIMP-1 is normally secreted and regulates extracellular matrix remodeling by binding matrix 
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metalloproteinases (Brew et al.,2000).  However, conflicting roles of TIMP-1 have been 
published in which TIMP-1 blocks tumor angiogenesis but is also associated with accelerated 
tumor progression (Loboda et al.,2006). 
The wild-type B. clarridgeiae-HMEC culture supernatant also contained proteins 
secreted by the bacteria.  Acetyl-coenzymeA acetyltransferase catalyzes the first step in the 
mevalonate metabolic pathway which results in energy production.   Most proteins need to be 
folded into a particular 3-dimensional structure in order to function, and GroEL and GroES are 
chaperonins, together with ATP, which cause the folding of many proteins (Lin and Rye,2006).  
Peptides matching B. henselae GroEL were identified in the wild-type culture media when the 
Rhizobiales-specific database was queried.   
The flaA mutant-infected HMEC culture media and the wild-type culture media 
contained 8 of the same proteins at higher concentrations than in the uninfected HMEC media.   
The significant differences were that the flaA mutant culture media had at least a 1.5-fold 
decrease in malate dehydrogenase.  A spot corresponding to GroEL was not detected.  Proteins 
identified in the flaA mutant culture media that were more concentrated than in the gels of the 
wild-type and motBC mutant media were galectin-1, ubiquitin conjugating enzyme E2, tissue 
inhibitor of metalloproteinase-1, stathmin, and triose phosphate isomerase.  In addition, a cluster 
of spots were all identified as vimentin, and some of the spots were significantly increased in the 
flaA mutant culture (Figure 16). 
Galectin-1 has intercellular and extracellular functions and is involved in integrin 
trafficking, adhesion, proliferation, and motility.  It binds many types of molecules including 
carbohydrates and proteins (Horiguchi et al.,2003; Scott and Weinberg,2004; Camby et al.,2006; 
Fortin et al.,2008).  Stathmin depolymerizes microtubules and is a critical component in 
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regulating the mitotic spindle of  replicating cells as well as in remodeling microtubules at the 
leading edge of migrating cells (Wittmann et al.,2004).  Ubiquitin conjugating enzyme E2 is part 
of the ubiquitin-proteasome system that degrades unneeded or misfolded proteins as mentioned 
earlier (Hilt and Wolf,2004).  Ubiquitin is a 76 amino acid protein that is attached to proteins by 
the ubiquitin conjugating enzymes and results in a target for the proteasome (Hilt and 
Wolf,2004).  Triosephosphate isomerase catalyzes the formation of glyceraldehyde-3 phosphate.  
And vimentin is an intermediate filament in the endothelial cytoskeleton (Gonzales et al.,2001). 
 
A.    B.     C.     D.   
Figure 17.  Vimentin.  2-D gel electrophoresis of culture supernatants, silver stained.  A. flaA 
mutant, B. uninfected control, C. wild-type B. clarridgeiae, D. motBC mutant. Similar results 
seen in Coomassie stained gels (not shown). 
A.    B.    C.     D.   
Figure 18.  Galectin.  2-D gel electrophoresis of culture supernatants, silver stained.  A. flaA 
mutant, B. uninfected control, C. wild-type B. clarridgeiae, D. motBC mutant. 
Pyruvate kinase, thioredoxin reductase, vimentin, DDAH, lamin A/C, insulin-like growth 
factor binding protein 7, as well as the bacterial protein acetyl-coA acetyltransferase were all 
decreased in the motBC mutant-HMEC co-culture media.  Proteins that were increased in the 
motBC mutant media compared to the uninfected control culture media included peroxiredoxin 
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1, SH3 domain binding glutamic acid rich protein and plasminogen activator inhibitor 1 from the 
endothelial cells and GroES and PPIC-type PPIase domain protein secreted by the B. 
clarridgeiae.  The GroES protein was 3-fold, 12-fold and 25-fold more concentrated than the 
uninfected culture in the wild-type, flaA, and motBC mutant cultures, respectively.  However, as 
with that of flaA, the motBC culture media did not produce detectable amounts of GroEL.  
A.   B. C.   D.  
Figure 19.  GroES.  A. Uninfected control HMECs.  HMECs infected with B. clarridgeiae: B.  
flaA mutant; C.  wild-type; D.  motBC mutant. 
 
Discussion 
Angiogenesis, the formation of new capillaries from existing blood vessels, is a key 
component of bacillary angiomatosis and other vasoproliferative diseases caused by B. 
bacilliformis, B. henselae and B. quintana.  Angiogenesis is also an important process during 
embryogenesis, development, wound healing and cancerous tumor progression.  The formation 
of new capillaries involves the degradation of the surrounding extracellular matrix, proliferation 
and migration of endothelial cells, and formation of tubules that then become new capillaries.  
Several molecules are capable of directly or indirectly stimulating angiogenesis including 
vascular endothelial growth factor (VEGF), nitric oxide (NO), hypoxia inducible factor (HIF), 
and angiopoietin-1 (Ang-1). 
We tested B. clarridgeiae wild-type, and two non-motile mutants that were devoid of 
flagella (flaA) or had flagella that were paralyzed (motBC) for their ability to invade human 
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microvascular endothelial cells (HMECs) and cause proliferation (Chapter 1).  All three strains 
were able to enter human endothelial cells but at different rates.  The flaA mutant was deficient 
in attachment, and the motBC mutant had the greatest percentage of attached and intercellular 
bacteria at later time points.  All three strains caused some cytotoxicity at an MOI of 100, but 
induced proliferation of HMECs at an MOI of 10.  The flaA mutant, however, induced more 
proliferation than the wild-type or motBC strains at an MOI of 10.  The mitogen responsible for 
Bartonella-induced angiogenesis remains elusive, although GroEL of B. bacilliformis has been 
recently implicated (Minnick et al.,2003; Smitherman and Minnick,2005).  We sought to 
determine if secreted proteins from the endothelial cells and/or bacteria were responsible for the 
different characteristics seen among the three B. clarridgeiae-HMEC co-cultures.  While there 
were proteins in common in the culture media of the 3 sets of infected HMECs, the wild-type, 
flaA and motBC protein profiles were different from one another. 
To better understand the significance of each protein identified in 2-D gel electrophoresis 
and MS/MS, the first question to address was whether the proteins found in culture supernatants 
are normally secreted by HMECs or other endothelial cells in culture.  Gene expression and total 
cellular protein content of normal and stimulated human endothelial cells has been studied 
previously (Bruneel et al.,2003; Scheurer et al.,2004; Gonzalez-Cabrero et al.,2007; Katanasaka 
et al.,2007).  However, the identity of proteins secreted (secretome) by human endothelial cells 
has not been well characterized to date.  Some conclusions may be drawn from data for the rat 
endothelial secretome (Pellitteri-Hahn et al.,2006).  Vimentin, plasminogen activator inhibitor-1, 
heat shock protein 70kDa protein 1 (Hsp70p1), pyruvate kinase, tissue inhibitor of 
metalloproteinase-1 (TIMP1), peroxiredoxins, alpha enolase and elongation factors were among 
the 225 proteins secreted by rat endothelial cells under normal conditions (Pellitteri-Hahn et 
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al.,2006).  Several of these proteins were identified in our study in all 4 cultures at equal 
concentrations and others were differentially secreted in the HMECs infected with B. 
clarridgeiae (Tables 3 and 4).  Therefore, it appears likely that many of the proteins we 
identified are normally secreted by HMECs and were not present due to cell lysis. 
The culture supernatants from both the HMECs infected with the B. clarridgeiae wild-
type and those infected with the flaA mutant strain exhibited an increase in pyruvate kinase, 
thioredoxin reductase, protein-L-isoaspartate-O-methyltransferase, Hsp70, triosephosphate 
isomerase and TIMP-1.  Pyruvate kinase is upregulated in proliferating cells, especially tumor 
cells, and is under the control of Ras, and transcription factors hypoxia inducible factor-1 (HIF-
1), SP1 and SP3 (Mazurek et al.,2005).   Up-regulation of the pyruvate kinase isoenzyme PK-M2 
is one of the hallmarks of cancer cells and is thought to help cells at the interior of a tumor 
survive in a low oxygen environment (hypoxia) (Mazurek et al.,2005).  PK-M2 was detected at 
3-fold higher concentration in hypoxic rat brain endothelial cells compared to normoxic 
conditions (Haseloff et al.,2006).  Thioredoxin reductase (TrxR), a selenoprotein, reduces 
thioredoxin which is an essential anti-oxidant in humans (Cox et al.,2008; Peng et al.,2008).  
Intracellularly, thioredoxin reduces diverse proteins including peroxiredoxin and transcription 
factors such as NFκB and AP-1 (Cox et al.,2008; Peng et al.,2008).  NFκB is only able to bind 
DNA in its reduced state. Thioredoxin also works with peroxiredoxin to increase HIF-1α 
expression and has been shown to do so under normoxic conditions in transfected breast cancer 
cells (Welsh et al.,2002). During oxidative stress and inflammation, thioredoxin is secreted by an 
unknown mechanism and is a co-cytokine and chemotactic factor (Arner and Holmgren,2000).  
TrxR was found to be actively secreted by peripheral blood mononuclear cells after stimulation 
by IFN-γ, LPS or IL-1α (Soderberg et al.,2000).  Because inhibition of TrxR results in inhibition 
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of cancer cell growth (Yoo et al.,2007), induction of apoptosis (Cox et al.,2008; Peng et 
al.,2008), and decreased HIF-1α and VEGF expression (Powis et al.,2006),TrxR is an attractive 
therapeutic cancer treatment target.  The increase in TrxR and PK seen in the wild-type and flaA 
supernatants may indicate hypoxia, oxidative stress and/or the presence of stimulated 
proliferating endothelial cells. 
Protein-L-isoaspartyl-O-methyltransferase, one of the proteins whose concentration was 
increased in wild-type and flaA-infected cells, is an enzyme that repairs damaged proteins.  
Synthesis of PIMT is significantly upregulated when bovine aortic endothelial cells become 
detached from their substratum (Lanthier and Desrosiers,2006).  Antibody to integrin αvβ3 
significantly reduced the upregulation of PIMT expression in human umbilical vein endothelial 
cells (HUVECs) (Lanthier and Desrosiers,2006).  However, Lanthier and Desrosiers point out 
that PIMT levels in attached and detached HMECs were equal to or higher than the level of 
upregulated PIMT seen in bovine cells or HUVECs (Lanthier and Desrosiers,2006).  Therefore, 
the up-regulation of PIMT seen in our HMECs infected with wild-type and flaA mutant strains 
of B. clarridgeiae compared to the uninfected cells may be due to a factor other than detachment 
from the substratum (plastic).  Recently, PIMT overexpression in pig aortic endothelial cells was 
found to prevent apoptosis induced by oxidative stress (Cimmino et al.,2008).  In addition, 
substrates for PIMT during oxidative stress include Hsp70 and Hsp90, actin and Bcl-xl 
(Cimmino et al.,2008).  Repair of deamidation sites on these proteins appears to be part of the 
anti-apoptotic response (Cimmino et al.,2008).    
Heat shock protein 70 (Hsp70) was found in the culture supernatants of the wild-type and 
flaA mutant-infected HMECs at a higher concentration than in the uninfected or motBC-infected 
media.  Hsp70 and other heat shock proteins are constitutively expressed and play an important 
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role in protecting newly synthesized proteins from degradation.  Hsp70 is overexpressed in some 
cancers (Aghdassi et al.,2007) and is often up-regulated during oxidative stress and after heat 
shock (Morano,2007).  In two separate proteomic studies, HUVECs stimulated with VEGF 
expressed increased amounts of Hsp70 protein (Pawlowska et al.,2005; Katanasaka et al.,2007). 
In addition, unlike in many cell types, Hsp70 is downregulated in HMECs and HUVECs under 
hypoxic conditions (Oehler et al.,2000; Eguchi et al.,2008).  Therefore, our data suggest that the 
wild-type and flaA-infected cells were stimulated but not hypoxic.   
Triosephosphate isomerase, an enzyme up-regulated in wild-type and flaA mutant 
cultures,  has been shown to be up-regulated in VEGF- or low dose ouabain-treated HUVECs 
(Qiu et al.,2007).  Ouabain is a poison from the foxglove seed that blocks the sodium-potassium 
pump, and the pharmaceutical version of it, digitalis, has been used to treat cardiomyopathy 
since 1785.  Recent studies have shown that at low doses, ouabain is mitogenic for HUVECs, but 
induces apoptosis at high doses (Qiu et al.,2008).   Because triosephosphate isomerase is 
important in glycolysis and energy production, it is reasonable to find it and other glycolytic 
enzymes up-regulated in proliferating cells.  Glycolytic enzyme expression is also upregulated 
by HIF-1, and an autocrine loop involves the end products of glycolysis, lactate and pyruvate, 
which promote HIF-1α protein stability (Lu et al.,2002; Milovanova et al.,2008).   
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is normally secreted from cells to 
regulate the matrix-degrading metalloproteinases.  Matrix metalloproteinases are important for 
angiogenesis because they disrupt the extracellular matrix allowing endothelial cells to detach 
and migrate (Reed et al.,2003).  TIMP-1, therefore, negatively regulates angiogenesis.  In 
contradiction to this, up-regulation of TIMP-1 has been linked with several types of cancers, and 
high concentrations of TIMP in cancer patient plasma is correlated with increased mortality and 
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poor outcome (Porter et al.,2005).  The function of TIMP as anti-angiogenic or anti-apoptotic 
may be tissue specific (Hornebeck et al.,2005).  In HMECs, TIMP was down-regulated during 
hypoxia (Loboda et al.,2006).  We found increased levels of TIMP-1 in the HMEC cultures 
infected with B. clarridgeiae wild-type and flaA mutant strains but not with the motBC strain.  
The protein profile showing increased pyruvate kinase, thioredoxin reductase, PIMT and Hsp70 
in the HMECs infected with the B. clarridgeiae wild-type and flaA mutant strains is most similar 
to the pro-angiogenic, anti-apoptotic scenario seen with HUVECs stimulated by exogenous 
VEGF (Pawlowska et al.,2005; Loboda et al.,2006; Katanasaka et al.,2007).  
Proteasome activator PA28 was found in the supernatants of the wild-type and flaA 
mutant co-cultures, but the proteasome subunit beta type 3 was at a lower concentration in the 
wild-type media compared to the uninfected and other two infected cultures.  The proteasome 
has an important role in cell cycle progression, apoptosis and signal transduction (Hershko and 
Ciechanover,1998).  Inhibition of the proteasome results in apoptosis, and a proteasome inhibitor 
is being evaluated in clinical trials as an anti-cancer treatment to induce apoptosis in tumor cells 
(Sterz et al.,2008).  However, other experiments indicate an important role of the proteasome in 
angiogenesis.  Lactacystin, a proteasome inhibitor, suppressed the formation of tubules in HMEC 
cultures and prevented the production and secretion of plasminogen activator, a known 
component of the angiogenic process (Oikawa et al.,1998).   The proteasome is made of 7 α and 
7 β subunits, and all are necessary for proteasomal function.  The significance of the β3 subunit 
in the media is unknown.  However, HepG2 cells secrete proteasome α 4 subunit (Higa et 
al.,2008), and proteasome subunit α type 6 is increased in VEGF-stimulated HUVECs 
(Pawlowska et al.,2005).    
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The flaA mutant-infected culture supernatant contained several proteins that were more 
concentrated in the 2D gels than the same spots in the other 3 gels including ubiquitin 
conjugating enzyme E2, galectin 1, stathmin and vimentin.  Ubiquitin conjugating enzyme E2 is 
part of the ubiquitin-proteasome system and is involved in labeling proteins for degradation by 
the proteasome.  It has been found to be down-regulated in pulmonary artery endothelial cells in 
hypoxic conditions and increased in gastric, breast and lung cancer cell lines (Manalo et 
al.,2005; Chen et al.,2006; Tedesco et al.,2007; Hao et al.,2008). 
Stathmin, galectin 1 and vimentin are all found at focal adhesions between endothelial 
cells and the extracellular matrix.  By destabilizing microtubules, stathmin is involved in the 
cytoskeletal remodeling that takes place in cell migration and it also regulates the mitotic spindle 
during cell proliferation (Wittmann et al.,2004).  Stathmin is up-regulated in many types of 
cancers, and inhibition of stathmin inhibits HUVEC proliferation, migration and tube formation 
(Mistry et al.,2007).  Galectin-1 is a carbohydrate binding protein with many functions.  It is 
secreted by endothelial cells and plays a role in adhesion to the extracellular matrix by cross-
linking integrins to laminin and fibronectin, as well as in cell motility through its reorganization 
of the actin cytoskeleton in conjunction with RhoA (Camby et al.,2006).  Galectin-1 expression 
was correlated with migration and invasiveness of glioblastoma cell lines (Jung et al.,2008).  
Galectin-1 is also mitogenic, and the concentration of galectin is associated with increased tumor 
progression (Camby et al.,2006).  Vimentin is an intermediate filament of the cytoskeleton and is 
linked to angiogenesis through an interaction with the αvβ3 integrins (Gonzales et al.,2001).  The  
αvβ3 integrins are expressed on endothelial and glial cells and mediate attachment to several 
ligands in the extracellular matrix during angiogenesis (Silva et al.,2008).  Ligation of αvβ3 
activates VEGF receptor signaling, activates the NFκB inflammatory reponse,  suppresses 
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apoptosis, and induces cell migration (Ruegg et al.,2004).  Anti-vimentin antibodies inhibit 
angiogenesis (van Beijnum et al.,2006), and vimentin  protein levels were shown to increase in 
whole cell lysates of hypoxic endothelial cells compared to cells in normoxic conditions 
(Scheurer et al.,2004).  Genes coding for vimentin, however, have not been shown to be 
upregulated by HIF-1 to date.  Taken together, the presence of increased concentrations of 
stathmin, galectin and vimentin in the flaA mutant media is indicative of early stages of 
angiogenesis in which endothelial cells proliferate and migrate.  The flaA protein profile 
correlates well with the increased mitogenicity of the flaA strain in MTT assays (Chapter I).  
Further tests are necessary to determine if the flaA mutant-infected cells have increased 
migration rates compared to the wild-type or motBC mutant-infected HMECs. 
In contrast to that of the wild-type or flaA mutant, the motBC-infected HMEC culture 
media exhibited a decrease in secretion of pyruvate kinase, thioredoxin reductase, vimentin, 
dimethylarginine dimethylaminohydrolase 1 (DDAH-1), lamin A/C and insulin-like growth 
factor binding protein 7 (IGFBP7).  Gastric cancer cells exhibit decreased expression of pyruvate 
kinase and thioredoxin reductase but show an increase in lamin A/C (Chen et al.,2006).  Other 
dissimilarities with angiogenic cancer cells include observations of colon cancer tumor 
endothelial cells in which both vimentin and IGFBP7 were reported to be up-regulated (van 
Beijnum et al.,2006).  IGFBP-7 is a secreted protein and has been found to be up-regulated in 
colorectal cancer cells and glioma cell lines and regulates glioma cell migration (Jiang et 
al.,2008).  Conversely, IGFBP-7 is down-regulated in prostate and breast cancer cells (Unterman 
et al.,1991), and loss of IGFBP-7 has been implicated in melanoma formation (Wajapeyee et 
al.,2008).  DDAH-1 and DDAH-2 metabolize asymmetric dimethyl-L-arginine which is a NO 
synthase inhibitor.  Enhanced expression of DDAH-1 in a glioma cell line increases angiogenesis 
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by increasing nitric oxide synthesis and secretion of VEGF (Kostourou et al.,2002).  However, in 
endothelial cells, DDAH-2 predominates, not DDAH-1 (Tran et al.,2000).  VEGF expression 
and secretion are up-regulated by over-expression of DDAH-2, not DDAH-1, in bovine aortic 
endothelial cells independently of the NO/NOS pathway (Hasegawa et al.,2006).  VEGF is 
upregulated when DDAH-2 binds to protein kinase A and phophorylates the transciption factor 
SP-1 which then binds to the VEGF promoter (Hasegawa et al.,2006).  DDAH-2 is also up-
regulated by low amounts of NO in a positive feedback loop (Sakurada et al.,2008).  DDAH-2 
was not identified in the culture supernatants in our study, but many spots subjected to MS/MS 
analysis did not yield positive identifications.  Also, we did not measure the transcription or 
translation rates of any genes.  Therefore, the expression and secretion levels of DDAH-2 in our 
study are unknown.   
The media from the HMECs infected with the motBC mutant strain had an increase, 
when compared to the uninfected control, in protein concentrations of malate dehydrogenase and 
PIMT similar to levels seen in the wild-type media.  However, the motBC mutant media had a 
24-fold increase in the protein identified as aldo-keto reductase family 1 B1 (aldose reductase), 
while both the wild-type and flaA media had a more modest 3-fold increase.  Aldose reductase is 
the rate-limiting enzyme in the polyl pathway in which glucose is reduced to sorbitol and then to 
fructose.  When glucose concentrations are high, excess glucose enters the polyl pathway and is 
reduced by aldose reductase.  The polyl pathway is also utilized for energy when oxidative 
phoshorylation is decreased due to low oxygen concentrations (Favaro et al.,2008).  A by-
product of the polyl pathway is ROS, reactive oxygen species, which cause oxidative stress if too 
concentrated.  ROS stimulate HIF-1 up-regulated VEGF expression and angiogenesis (Xia et 
al.,2007).  In diabetes, this angiogenesis can lead to retinopathy, nephropathy and other 
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microvascular complications (Chung and Chung,2005).  Microvascular changes caused by 
hyperglycemia and diabetes include endothelial cell junction disruption, increased vascular 
permeability and blocked retinal capillaries (Caldwell et al.,2005).  The blockage of blood flow 
then leads to hypoxia, HIF-1 activation, VEGF expression and proliferation. (Caldwell et 
al.,2005).  Significantly, more than 50 articles have been published describing cases of 
neuroretinitis and other ocular manifestations caused by infection with B. henselae, B. quintana 
or B. grahamii have been reported (Kerkhoff et al.,1999; Michau et al.,2003; Mason,2004).  To 
date, only B. henselae has been shown to cause hypoxia, but the other species may do the same 
or trigger angiogenesis in another manner causing symptoms similar to diabetic retinopathy.  
The motBC mutant media had an 8-, 11- and 40-fold increase in the concentrations of 
peroxiredoxin 1, plasminogen activator inhibitor 1 (PAI-1), and SH3-domain binding glutamic 
acid rich protein 3 (SH3BGRL3), respectively.  Peroxiredoxin 1 expression increases in 
HUVECs stimulated with VEGF (Katanasaka et al.,2007) and in cells undergoing oxidative 
stress (Immenschuh and Baumgart-Vogt,2005).  Patients with diffuse systemic sclerosis have 
lesions in which angiogenesis of dermal HMECs is impaired but the pattern of gene expression is 
pro-angiogenic and includes an increase in peroxiredoxin 1 (Giusti et al.,2006).  SH3BGRL3 is a 
member of the thioredoxin super family but its function is unknown (Xu et al.,2005).  Both 
SH3BGRL3 and PAI-1 are markers of poor prognosis in some cancers (Aviel-Ronen et al.,2008) 
even though PAI-1 has been shown to inhibit angiogenesis (Deng et al.,1996).  PAI-1 is a 
secreted serine protease inhibitor (SERPINE1) and directly inhibits tissue plasminogen activator.  
When not inhibited, plasminogen activator converts plasminogen in the extracellular matrix to 
plasmin which then cleaves FasL and induces apoptosis (Bajou et al.,2008).  The effect of PAI-1 
appears to be dose-dependent, and low doses promote angiogenesis by inhibiting FasL-mediated 
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apoptosis (Bajou et al.,2008).    HIF-1α is the major transcription factor involved in PAI-1 
expression during hypoxia (Fink et al.,2002).  PAI-1 is up-regulated in cysteine-rich 61 (Cyr61)-
induced gastric cancer cell invasion in an HIF-1-dependent manner (Lin et al.,2008).  HUVECs 
infected with Rickettsia rickettsii show an increase in PAI-1 mRNA stability, protein expression, 
and secretion (Shi et al.,1998), while bovine aortic endothelial cells demonstrate an increase in 
PAI-1 transcription rate following exposure to LPS, TNF-α or TGF-β (Sawdey et al.,1989).  The 
gene for PAI-1 also has binding sites for transcription factors NFκB, SP-1, Smad and AP-1.  
Given that PAI-1 secretion was increased 10-fold in the motBC-infected HMEC supernatant, 
aldose reductase was increased 24-fold, TIMP was not increased, and thioredoxin reductase was 
decreased, the motBC-infected HMECs appear to be undergoing hypoxia and oxidative stress 
(Scheurer et al.,2004; Loboda et al.,2006). 
B. henselae causes hypoxia and activation of HIF-1 in HUVECs.  In addition, several 
HIF-1 regulated genes have been shown to be up-regulated in B. henselae-infected cells 
including VEGF, adrenomedullin, insulin-like growth factor binding protein 3, and alpha enolase 
(Kempf et al.,2005).  We did not find any of those proteins in the culture supernatant of the 
HMECs infected with B. clarridgeiae.  However, many of the protein spots did not generate 
conclusive identifications after MS peptide mass fingerprinting.  It is not known whether B. 
bacilliformis causes hypoxia, but B. bacilliformis infected HMECs up-regulate HIF-1α 6 hours 
after inoculation, and HIF-2α and and HIF-3α  after 1 hour (D. Kohlhorst, PhD dissertation).  
HIFs regulate over 100 other genes including VEGF receptors, erythropoietin, plasminogen 
activator inhibitor 1 (PAI-1), nitric oxide synthase 2, proteasome activator, proteasome subunits, 
ubiquitin conjugating enzymes, transcription factors, oxidoreductases, and cell surface receptors 
(Manalo et al.,2005; Hirota and Semenza,2006).  In hypoxic conditions, VEGF is up-regulated 
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by HIF-1, is secreted and causes proliferation in an autocrine fashion.  VEGF is also secreted by 
other cells in vivo, including macrophages, and stimulates endothelial cells in a paracrine 
angiogenic loop.  VEGF-stimulated HUVECs in vitro have increased concentrations of heat 
shock 70 protein 8, heat shock 90 protein 1, peroxiredoxin 1, and many other proteins involved 
in signal transduction (integrins), glycolysis (pyruvate kinase), cytoskeletal regulation (vimentin) 
and metabolism (aldehyde dehydrogenase) (Pawlowska et al.,2005; Katanasaka et al.,2007).  
Most of these proteins have been found in the extracellular milieu in our study.  The HMECs 
were not tested for hypoxia in our experiments, but the pH of the culture media remained neutral 
indicating that hypoxia, if it did occur, was not caused by bacterial overgrowth.   
The different profiles of secreted human proteins identified in the culture supernatants of 
HMECs infected with the wild-type, the flaA mutant or the motBC mutant of B. clarridgeiae 
indicate that the 3 strains induced different responses by the HMECs.  The wild-type strain 
caused a pro-angiogenic response, and the flaA mutant-infected HMECs secreted proteins 
involved in cytoskeletal rearrangements indicative of cell migration.  Proteins known to be 
expressed under hypoxic conditions and/or by HIF-1 up-regulation were secreted by the motBC 
mutant-infected cells.  We next examined the spots on 2-D gels that were identified as 
homologous to predicted proteins of B. bacilliformis, B. henselae and other close relatives to get 
clues as to the manner in which the different HMEC responses were induced.  The bacterial 
proteins identified in the culture supernatants were peptidyl prolyl cis/trans isomerase C (PPIC)-
type PPIase domain protein, GroEL, and GroES. 
A PPIC-type PPIase domain protein was found at a higher concentration in the motBC 
mutant-infected culture supernatant than the uninfected HMECs or the HMECs infected with 
either the wild-type B. clarridgeiae or the flaA mutant strain.  Proteins that contain a PPIC-type 
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PPIase domain have been found in human cells (cyclophilins) as well as bacteria, fungi and 
plants and are involved in protein folding.  Some PPIases are found in the bacterial periplasm 
and some, such as the Mip protein in Legionella, are outer membrane proteins (Debroy et 
al.,2006).  The peptidyl prolyl isomerase SurA is a virulence determinant in Proteus mirabilis 
(Himpsl et al.,2008).  Homologues of SurA have been found in E. coli, Brucella spp. and 
Shigella flexneri and are critical for folding of outer membrane proteins (Lazar and Kolter,1996; 
Dartigalongue and Raina,1998; Delpino et al.,2007; Purdy et al.,2007; Watts and Hunstad,2008).  
B. tribocorum has an identified surA gene (BT_0824), and hypothetical proteins in the B. 
quintana, B. henselae and B. bacilliformis genomes are 81% identical to the SurA of B. 
tribocorum.  B. clarridgeiae most likely also has a surA homologue.  Helicobacter pylori 
secretes a PPIase HP0175 which binds TLR4 in human gastric epithelial cells and activates 
apoptosis signal regulating kinase 1 (Basak et al.,2005).  A human peptidyl-prolyl isomerase, 
Pin1, is over-expressed in many types of cancer cells and has recently been found to stimulate 
VEGF expression by activating HIF-1α and AP-1(Kim et al.,2008).  It would be interesting to 
determine if the B. clarridgeiae PPIase has a similar effect on HMECs. 
A GroEL homologue was identified in the wild-type B. clarridgeiae culture supernatant 
but was not found in the other two bacterial co-cultures or the uninfected control.  GroES was 
found in all three supernatants from the infected HMECs, but was most concentrated in the 
motBC gel and was least concentrated in the flaA gel (Figure 19).  Given that the inocula and 
growth curves were similar for all three strains, a higher concentration of one strain over another 
cannot account for these differences.  GroEL is actively secreted by B. bacilliformis and 
participates in the bacterial lystate‟s mitogenic effect on HUVECs (Minnick et al.,2003).  
Antibodies against GroEL or GroES reduced the mitogenicity of B. bacilliformis cell lysates by 
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40% suggesting that these proteins are involved in but are not solely responsible for the 
proliferative effect of the lysate (Minnick et al.,2003).  The genes groEL and groES are co-
transcribed in B. bacilliformis (Callison et al.,2005), but it is unknown by what mechanism 
GroEL is secreted and whether GroES is secreted by the same mechanism.  What is known, 
however, is that B. bacilliformis does not have a VirB T4SS, and the VirB system of other 
Bartonella species has been ruled out as a participant in the proliferative effect on human cells 
(Schmid et al.,2004).  We have confirmed that both GroEL and GroES were secreted by the 
wild-type B. clarridgeiae, but only GroES was secreted by the flaA or motBC mutant.  It appears 
that the secretion of GroEL, but not GroES, requires a complete flagellar system.     
Secretion of virulence factors by the flagellar T3SS has been demonstrated in 
Campylobacter jejuni, Yersinia enterocolitica and Serratia liquifaciens.   In these organisms, 
secretion requires a minimal flagellar apparatus including the hook and basal body and flagellar 
T3SS (Givskov et al.,1995; Young et al.,1999; Young and Young,2002; Konkel et al.,2004; 
Guerry,2007).  If the gene expression hierarchy for B. clarridgeiae flagellar assembly is similar 
to that elucidated for other bacteria, the flaA and motBC mutants are predicted to have a minimal 
flagellar structure and flagellar T3SS.  This appears not to be sufficient for GroEL secretion, or 
the flaA and motBC mutations affect another necessary and as yet unknown component for 
secretion of GroEL.      
The increased secretion of GroES by the motBC mutant is similar to virulence factor 
secretion by a Vibrio cholerae flagellar motor mutant.  The flagellar T3SS of Vibrio cholerae 
and the type 2 secretion system (T2SS) appear to interact.  Vibrio cholerae secretes 
hemagglutinin/protease HapA and cholera toxin (CT) by a T2SS.  Secretion of CT and HapA 
were significantly increased in a mutant with an interrupted gene encoding the flagellar motor 
 86 
 
stator MotY (Silva et al.,2006).  The polar flagellum of V. cholerae is driven by a sodium pump 
rather than a proton pump, and a sodium channel inhibitor decreased the secretion of CT in a 
wild-type strain and the motY mutant indicating that the sodium channel was still functioning in 
the untreated mutant (Silva et al.,2006).  The authors hypothesized that the energy not used to 
produce flagellar torque in the motY mutant was used for secretion.   
Crosstalk between the flagellar system and the general Type III secretion system in Y. 
enterocolitica has been reported.  The Yop (yersinia outer proteins) virulence factor secretion 
system is negatively regulated by the flagellar master regulator FlhDC (Bleves et al.,2002).  
Expression of the Y. enterocolitica flagellar T3SS is inversely proportional to the expression of 
the Yops T3SS (Wilharm et al.,2004).  Furthermore, the Yops T3SS is dependent on the proton 
motive force of the flagellar motor but Yops were secreted in a motAB mutant  (Wilharm et 
al.,2004).  If the flagellar system in B. clarridgeiae and B. bacilliformis is constructed like that of 
their relative Sinorhizobium meliloti, the motor consists of MotAB (Platzer et al.,1997).  MotC, 
which binds MotB, has been proposed as an energy transducer for the flagellar motor (Platzer et 
al.,1997). Flagellin and MotC also appear to be important for crosstalk between the flagellar 
system and the general Type III secretion system in P. aeruginosa.  Gene expression of the T3SS 
regulon, secretion of the ExoS effector, and cytotoxicity were all decreased in motAB and motY 
mutants but increased in the motBC mutant and a fliC (flagellin) mutant (Soscia et al.,2007).  
There may be crosstalk between secretion systems in B. clarridgeiae, as the motBC mutation 
caused a marked increase in GroES and PPIC PPIase secretion.  However, the levels of GroES, 
as determined by 2-D gel electrophoresis, in the culture supernatant of the flaA mutant-infected 
cells were less than in the wild-type strain which may indicate a requirement for contact between 
the bacteria and HMECs.  More work is needed to determine the gene expression hierarchy in 
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Bartonella flagellar assembly as well as the molecular mechanisms and pathways involved in 
regulating the secretion systems. 
The master regulator for Bartonella flagellum protein synthesis and assembly has not 
been determined.   FtcR has been identified in Brucella melitensis, a close relative of Bartonella, 
as a master regulator of flagellar gene expression (Leonard et al.,2007).  A DNA-binding 
response regulator in the B. bacilliformis genome (BARBAKC583_1123) has 78% amino acid 
similarity to FtcR and is a potential candidate for the master regulator role.  Other regulators 
have been shown to control flagellar and general T3SSs directly or indirectly.  In Bordetella 
bronchiseptica, expression of the sensor kinase and response regulator BvgAS negatively 
regulates flagellar gene transcription and motility but positively regulates T3SS secretion of 
virulence factors (Akerley and Miller,1993; Han et al.,1999; Mattoo et al.,2004).  The two 
component system BarA/SirA in Salmonella indirectly represses the flagellar system upstream of 
the flhDC master regulator genes  and directly activates the HilA virulence regulon (Teplitski et 
al.,2003).  The genomes of B. bacilliformis, B. henselae, B. quintana and B. tribocorum contain 
several genes for sensor histidine kinases/response regulator two-component systems including 
BatRS which are homologous to Bvg.  The batR and batS genes were partially sequenced from 
B. clarridgeiae during this study when non-motile transposon mutants were initially screened, 
(data not shown).  The role of BatRS in Bartonella virulence, and specifically in regulation of the 
flagellar system, is undetermined.   
The profile of proteins secreted by motBC-infected HMECs is indicative of cells that are 
experiencing hypoxia.  Proliferation of HUVECs and HMECs is triggered, at least in part, by 
hypoxia and the subsequent activation of HIF-1 after B. henselae infection (Kempf et al.,2005).  
Other bacteria, however, activate and/or stabilize HIF-1 without hypoxia, as do some viruses 
 88 
 
(Nasimuzzaman et al.,2007).  Y. enterocolitica, S. enterica subspecies enterica and E. aerogenes 
co-cultured with HMECs activated HIF-1 at a higher level than B. henselae and in an oxygen-
independent manner (Hartmann et al.,2008).  In addition, it was determined that the 
Enterobacteriaceae‟s siderophores (yersiniabactin, salmochelin and aerobactin) were critical for 
HIF-1 activation and VEGF secretion, and bacteria-host cell contact was not necessary 
(Hartmann et al.,2008).  Siderophore-dependent induction of HIF-1-regulated adrenomedullin 
and hexokinase were also reported (Hartmann et al.,2008).  The siderophores may compete with 
the host cells for iron.  Iron deprivation would then cause the prolyl hydroxylases, which require 
iron, to be unable to hyroxylate the HIF-1α molecules and target them for degradation (Hartmann 
et al.,2008).  The siderophore enterobactin has recently been shown to induce a pro-
inflammatory response in respiratory epithelial cells in vitro resulting in secretion of IL-8, the 
product of an NFκB-regulated gene (Nelson et al.,2007).  Siderophores have not been described 
for Bartonella species; however, they are produced by close relatives of Bartonellae such as 
Brucellae and S. meliloti.  In addition, the B. henselae, B. bacilliformis and B. tribocorum 
genomes contain ferric anguibactin (siderophore) transport system gene homologues.  
Siderophores may be an additional virulence factor for Bartonella. 
If secretion of proteins is an indication of an intracellular increase in production of those 
proteins, given previous results, the presence of increased Hsp70 and TIMP-1 in the culture 
supernatants of the wild-type and flaA-infected HMECs suggests that proliferation is occurring 
without hypoxia (Oehler et al.,2000; Loboda et al.,2006).  Minick and co-workers reported that 
GroEL has a role in mitogenicity induced by B. bacilliformis perhaps by acting as a chaperone 
for an unidentified protein or by directly triggering signal transduction and cytokine secretion 
(Minnick et al.,2003).  Recently, incubation of purified B. bacilliformis GroEL with HMECs 
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revealed a significant increase in the tubule formation that is characteristic of angiogenesis (D. 
Kohlhorst, Ph.D. Dissertation).  We found that only the wild-type strain of B. clarridgeiae 
secreted GroEL suggesting that the flagellar complex has a direct or indirect role in GroEL 
secretion.  The flaA mutant induced more proliferation than the other strains at an MOI of 10, 
and the galectin, stathmin and vimentin identified in the supernatant are indicative of cytoskeletal 
rearrangement and cell migration.  The bacterial factors secreted by the flaA mutant that could 
account for the cytoskeletal changes and proliferative effect were not identified, but GroEL was 
not found.   The motBC strain attached and entered the HMECs better than the wild-type strain, 
and proteins found in the culture supernatant suggest that the HMECs were undergoing hypoxia.    
A high concentration of GroES in the culture media may indicate that a non-flagellar T3SS or 
other type of secretion system was up-regulated in the motBC mutant.  Crosstalk between 
secretion systems may be occurring in a similar fashion to that found in P. aeruginosa in which a 
flagellin mutant and a motCD mutant each demonstrated increased secretion of virulence factors 
through the general T3SS (Chapter I, (Soscia et al.,2007)). 
If GroEL is secreted by all Bartonella species, it may be secreted by the flagellar T3SS in 
B. bacilliformis, B. clarridgeiae and the other flagellated Bartonella, and secreted by the Trw 
secretion system in the Bartonella lacking flagella.  It has been proposed that the Trw system has 
replaced flagella during radial speciation (Dehio,2008).  B. clarridgeiae is motile but does not 
swim particularly well, and the ancestral species B. bacilliformis does not have genes encoding 
typical chemotaxis proteins such as CheW or CheY.  This may indicate that the flagellar system 
in Bartonella in addition to or other than motility.  We found that the non-motile flagellated 
motBC mutant attached to and entered the HMECs better than the wild-type strain.  The 
Bartonella flagellar system, therefore, may be used more as a T3SS than for motility. 
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SUMMARY 
B.bacilliformis, B. henselae and B. quintana are pathogenic for humans and cause 
vasoproliferative diseases in immunosuppressed or immunocompromised individuals.  B. 
clarridgeiae has been implicated in human infections such as cat scratch disease, yet the 
bacteria have never been isolated directly from human clinical specimens.  B. clarridgeiae 
has been found in cats and has been postulated to be the etiologic agent of endocarditis and 
hepatic disease in dogs (Chomel et al.,2001; Gillespie et al.,2003).  If B. clarridgeiae is 
capable of causing vasoproliferative disease in humans characterized by angiogenesis, one of 
the first steps would most likely be invasion of endothelial cells.  We tested B. clarridgeiae 
with human microvascular endothelial cells in vitro and found that the bacteria formed clumps 
on the endothelial cell surface but entered the cell as individual bacteria.  The endothelial cells 
proliferated in the presence of B. clarridgeiae, particularly at a low inoculum of MOI 10.  A 
high MOI of 100 was cytotoxic.   
Two non-motile mutants of B. clarridgeiae were created to evaluate the role that the 
flagellar system may play in virulence.  The flaA gene was disrupted in one mutant and no 
flagella were visible by microscopy.  A flagellar motor mutant with a disruption of the motB 
and motC genes had paralyzed flagella.  Both mutants entered endothelial cells as single 
bacteria, and the motBC mutant attached to and entered the endothelial cells significantly better 
than the flaA mutant.  One of the motBC-infected cells showed signs of increased cytoskeletal 
involvement (lamellipodia and filopodia) by electron microscopy, but a qualitative assessment 
of changes in cytoskeletal features was not performed.  Both mutants caused proliferation of 
the endothelial cells, but the flaA mutant had a more dramatic increase in proliferation than the 
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wild-type or motBC mutant.  The flaA and motBC mutants caused cytotoxicity at high doses 
similar to that of the wild-type. 
The proliferative effect of the flaA mutant and the increased invasion by the motBC mutant 
were similar to the effects of a virB4 deletion in B. henselae.  The increased proliferation by 
the virB mutant was postulated to be due to the elimination of cytostatic and cytotoxic effects 
of VirB (Schmid et al.,2004).  The increased invasion was thought to be due to increased 
endocytosis which would engulf B. henselae faster than the VirB-dependent invasome 
formation would (Schmid et al.,2004).  B. clarridgeiae has virB genes but it is not known 
whether the VirB system is functional.   A relationship between the flagellar system and VirB 
has not been postulated previously, perhaps because the well-studied Bartonella species do not 
possess both systems.   B. bacilliformis does not have a VirB system, and B. henselae and B. 
quintana do not have a flagellar system.  However, crosstalk between the flagellar system and 
the general T3SS in P. aeruginosa and Y. enterocolitica have been reported (Wilharm et 
al.,2004; Soscia et al.,2007), as well as crosstalk between the flagellar system and the T2SS in 
V. cholerae (Silva et al.,2006).  B. clarridgeiae offers the opportunity to investigate an 
interaction between the flagellar T3SS and the VirB T4SS in the future. 
The chaperonin GroEL was identified in the culture supernatant of the HMECs infected 
with the wild-type B. clarridgeiae but not in the flaA or motBC cultures.  This was surprising 
considering that GroEL was thought to be involved in the mitogenicity of B. bacilliformis 
(Minnick et al.,2003), and the B. clarridgeiae flaA mutant in our study induced more 
proliferation than the wild-type strain.  We conclude that GroEL secretion requires a complete 
flagellar system.  GroES, a co-chaperonin, was found at a higher concentration in the motBC 
mutant culture than in the culture supernatants of the flaA mutant or wild-type.  This result may 
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indicate that another export system was up-regulated due to the flagellar motor mutation, as 
seen in other bacteria.  The low concentration of GroES was inversely proportional to the 
degree of proliferation induced by the flaA mutant.  The high concentration of GroES in the 
supernatant was associated with the strain that was highly invasive (motBC).  Studies with B. 
bacilliformis by Minnick et al., and Kohlhorst (GSU) have examined the effect of GroEL levels 
on HUVECs and found that low concentrations of GroEL are mitogenic and high 
concentrations are inhibitory (Minnick et al.,2003; Smitherman and Minnick,2005)(D. 
Kohlhorst, PhD Dissertation 2008).  However, GroES levels were not measured in those 
studies.  Determining the role of GroES and GroEL in proliferation of endothelial cells and 
invasion by B. clarridgeiae and other Bartonella species will require further investigation.    
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